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Abstract 
Saltuk B. Hanay 
Polypeptide Based Hydrogels 
There is a need for biocompatible, biodegradable, 3-D printable and stable hydrogels 
especially in the areas of tissue engineering, drug delivery, bio-sensing technologies 
and antimicrobial coatings. The main aim of this Ph.D. work was to fabricate 
polypeptide based hydrogel which may find a potential application in those fields. 
Focusing on tyrosine or tryptophan-containing copolypeptides prepared by N-
Carboxyanhydride (NCA) polymerizations, three different crosslinking strategies have 
been tested to obtain polypeptide hydrogels. 
1- Enzymatic crosslinking of tyrosine (Chapter 2):  Horseradish peroxidase (HRP) 
enzyme crosslinks tyrosine via a radical formation mechanism. There are several 
reports of HRP crosslinked tyramine modified natural polymers such as chitosan, 
hyaluronic acid. However, when a library of tyrosine containing synthetic polypeptides 
was tested for HRP crosslinking, none of resulted in gel formation.  
2- TAD click crosslinking of tyrosine (Chapter 3): 4-Phenyl-1,2,4-triazole-3,5-dione 
reacts (PTAD) with tyrosine in a click-like manner.
1
 Tyrosine copolypeptides were 
successfully reacted with commercially available PTAD. Then, a series of 
monofunctional and bifunctional TAD compounds were synthesized and tested. 
Hydrogels were obtained by crosslinking copolypeptides with hexamethylene-bisTAD. 
Although TAD-tyrosine reaction is fast and selective, TADs’ instability in aqueous 
conditions is a limitation for this system.  
3- TAD click crosslinking of tryptophan (Chapter 4): Methyl-TAD reacts with 
indole groups very fast, efficiently and reversibly in organic solvents.
2
 Tryptophan 
(indole-containing amino acid) NCA monomer was synthesized, characterized and 
copolymerized with PEG-amine, Z-Lys, and BLG NCAs. Novel mono and 
bifunctional PEG-TADs were also synthesized. The polypeptides were PEGylated and 
crosslinked to produce hydrogels.  
4- Novel organohydrogels (Chapter 5): The successfull strategy from Chapter 4 was 
further applied to produce novel organohydrogels gels with defined segments. Control 
over gelation kinetics was demonstrated by the hexamethylene-bisTAD reaction with 
tryptophan containing copolypeptides. Applying controlled lysine and glutamic acid 
deprotection, non-toxic organohydrogel consisting of a hydrophobic core and a 
hydrophilic shell were obtained.  
 
1 
 
 Chapter 1 
 Polypeptide-Based Hydrogels 
1.1. Introduction 
Polypeptides (or proteins) are common building blocks of living matter as they play a 
crucial role in metabolic activities and the interaction between organisms and the 
environment. Polypeptide-based hydrogels hold great potential to be used as 
biomedical responsive materials for tissue engineering, drug delivery and 
therapeutics.
1–3
 The last decade has shown that there is still a need for new smart 
materials which can mimic natural tissues and interact with cells without causing a 
foreign body reaction.
4–7
 For example, the fabrication of an artificial extracellular 
matrix (where cells can grow, migrate and form tissues inside) is still a challenge 
because a polymeric scaffold must meet many criteria such as being biocompatible, 
scalable and meeting the desired mechanical properties.
6,8–10
  
1.1.1 Tissue Engineering Applications 
Tissue engineering is a recently established interdisciplinary field covering medicine, 
molecular biology, chemistry and engineering.
11–13
 The first tissue engineered 
examples were reported in 1981 when scientists developed an artificial skin used to 
treat burn victims.
14,15
 The main steps of tissue engineering are shown in Figure 1. It 
starts with proliferation of stem cells which are taken from the patients’ body. One 
strategy involves printing cells and polymer together (bioprinting) during scaffold 
fabrication utilizing UV-curing approaches. However, crosslinkers or UV irradiations 
are not generally compatible with cells. The other strategy is to load proliferated stem 
cells into a pre-made synthetic scaffold or into a decellularized donor organ.
16–18
 
Premade scaffolds can be washed to remove non-compatible reagents and be sterilized 
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to make hydrogels biocompatible. Recently, 3D-printing and 3D-bioprinting 
technologies were utilized to create hydrogels with complex shapes and geometries.19–25  
Hydrogels for tissue engineering can be prepared from natural polymers such as 
collagen, chitosan, silk or from synthetic polymers such as polyethylene glycol, 
polyphosphazene or polypeptides.
26,27
 Natural polymers have the advantage of 
biocompatibility which is a prime requirement for tissue engineering.
28
 However, 
drawbacks of natural polymers are related to their scalability and compositional 
inconsistency depending on the source which they are isolated from.
29 
On the contrary, 
synthetic polymers can be produced industrially in large scales and their chemical 
composition can be controlled to a large extent. The main challenges for synthetic 
polymers are generally related to their biocompatibility. In this context, synthetic 
polypeptides hold great potential for future biomaterials as they combine natural 
building blocks (biocompatibility, biodegradability) with the advantages of synthetic 
flexibility.  
 
Figure 1.1. The general approach for fabricating tissues using the patient's own cells. 
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1.1.2 Drug Delivery Applications 
Stimuli-responsive hydrogels can be used to create advanced drug delivery systems.
30
 
For example, Kopecek’s and co-workers demonstrated that a pH responsive and 
biodegradable hydrogel releases drugs mostly in the colon after enzymatic degradation 
of the hydrogel network.
31
 As seen in Figure 1.2, carboxylates (COO
-
) become non-
ionized due to low pH of the stomach. The neutralization of carboxylic acid causes 
shrinkage of the hydrogel network. Therefore, the diffusion of the drug becomes 
minimized in the stomach. When the hydrogel passes into the small intestine, higher 
pH causes reionization of COOH groups. Thus, the hydrogel swells again and the gel 
network expands. At this stage, the release of the drug becomes much higher as pores 
increase. Finally, the azoaromatic crosslinks are broken by colon enzymes and all the 
drug molecules released at much higher rate. Similarly, a hydrogel having cationic side 
groups (such as lysine) swells under acidic conditions and shrinks under basic 
conditions. In addition to pH, electric
32,33
,light
34–36
, pressure
37
, glucose
38–40
, and 
antigen
41
 sensitive hydrogels are reported. 
 
Figure 1.2. Stimuli-responsive biodegradable hydrogel with controlled drug release.
31 
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1.1.3 Synthesis of Polypeptides 
Biodegradability is a common challenge in the design of advanced drug delivery 
systems. Synthetic polypeptides might overcome this since the peptide bonds are 
enzymatically and chemically degradable. Synthetic polypeptides can be prepared by 
four different methods as briefly highlighted below. Each of these strategies has its 
specific advantages and disadvantages.   
NCA Polymerization: Ring-opening polymerization of N-carboxyanhydrides (NCA) 
is a very convenient way to synthesize polypeptides in bulk amounts. High yield, ease 
of synthesis and control over molecular weight makes NCA polymerization one of the 
most common methods to prepare polypeptides. While an exact amino acid sequence 
cannot be achieved, homo polypeptides, block polypeptides, complex polypeptide 
architectures or glycopeptides can be prepared by this technique .
42–49
 
Solid Phase Peptide Synthesis: In SPPS, amino acids are added to each other one by 
one. Monodisperse polypeptides with precisely controlled sequences can be obtained 
by this method. However, SPPS is not convenient to prepare large scale or long chain 
polypeptides (> 50 units) because of the lower yield and challenging purification after 
each addition of amino acid.
50–55
 
 
Protein Engineering: Protein engineering is a method to prepare polypeptides by 
expression of artificial genes in a living organism such as bacteria. It has been shown 
that protein engineering can be used to synthesize natural proteins such as silk, 
collagen, and elastin.
56,57
  
Self-Replication: In this technique, a template is used to synthesize sequentially 
controlled polypeptides. Reactants are pre-organized and catalyzed by a template to 
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replicate the template. Self-replication is complex but exciting field since it may find 
solution to how life started and evolved.
58 
1.1.4 Polypeptide-Based Hydrogels 
Natural polypeptides are proteins which are isolated from animals or plants. The most 
common proteins used in biomaterial applications are collagen, gelatin, fibrinogen, and 
silk. Although the quality and type varies depending on the source, they have 
significant advantages such as degradability as well as having cell or growth factor 
binding sequences.
59
  Additionally, their gelations are mostly due to self-assembly into 
specific chain formations such as α-helix, β-sheets, and fibrils.60–62 The self-assembly 
character of these polypeptides can be exploited to prepare stimuli-responsive 
injectable hydrogels. For example, a collagen solution at room temperature forms a 
physically crosslinked hydrogel when the temperature is raised to 37
o
C. The 
microstructure of these types of hydrogels can be easily tuned by pH, ionic strength or 
speed of heating to the desired temperature. The drawback of physically-crosslinked 
hydrogels is their low mechanical strength. In general, they are not mechanically 
robust materials. One way to increase the strength of these hydrogels is chemical 
crosslinking or modification of natural polypeptides. Bisaldehydes, amidation coupling 
agents, disocyanates or other functional groups can be used to covalently crosslink 
proteins or polypeptides. Alternatively, an acrylate modified gelatin can be hardened 
by UV or thermal irradiation.
63,64
  
1.1.5 Hydrogels from synthetic polypeptides 
Physical crosslinking of synthetic polypeptides can be achieved by non-covalent 
interactions such as H-bonding, hydrophobic interactions, van der Waals, coulombic 
interactions, and self-assembly.
1,9,65
 Their crosslinking or properties can also be altered 
by an external stimulus such as pH, temperature or ionic strength.
66–68
 Amphiphilic 
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diblock or triblock polypeptides prepared by NCA polymerization can form physically 
crosslinked hydrogels.
62,69–72
. These types of gels are mechanically weak but they are 
stimuli-responsive. On the other hand, covalent crosslinking provides stronger 
materials. 
Ahrens et al. prepared polypeptides having alkyne side groups and  functionalized 
them with N3-PEG-maleimide and N3-PEG-Norbornene.
73
 Additionally, hydrogels 
were obtained by crosslinking maleimide groups with 4-arm PEG-thiol. The authors 
showed that the attachment of human mesenchymal stem cell (hMSC) in peptide-PEG 
hybrid is more effective than in PEG-only gels. It is important to notice that this 
hydrogel is uncharged. It was shown that charged polypeptide materials cause 
cytotoxicity or non-binding of cells when the chain length is small. However, longer 
chain copolypeptides of charged amino acids such as poly(˪-lysine)-block-poly(˪-
leucine) displayed good biocompatibility.
74
 Wang et al. used the non-toxic 
crosslinking agent genipin to obtain hydrogels from lysine containing 
copolypeptides.
75
  They demonstrated that block copolypeptides of lysine-alanine and 
lysine-glycine have good biocompatibility. Additionally, control over mechanical 
properties, enzymatic degradability, and successful cell attachments were achieved. 
Hartgerink’s group also reported a lysine-containing polypeptide hydrogel which was 
crosslinked in mammalian cell culture conditions. The crosslinking was due to 
oxidation of lysine and Schiff base formation by lysyl oxidize enzyme which naturally 
occurs in the serum (Figure 1.3).
76 
Not relying on NCA polymerization or SPPS, Lim et al. obtained hydrogels from a 
synthetic polypeptide synthesized by E. coli.
77
 They genetically modified E.coli to 
produce elastin-like polypeptides (ELP). ELP consist of repeating Valine-Proline-
Glycine-X-Glycine where X is a natural amino acid but different from proline. They 
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have periodically introduced lysine groups to the X position. Then hydrogels were 
obtained by crosslinking lysine residues with [tris(hydroxymethyl)phosphino] 
propionic acid. 
 
Figure 1.3. Schiff base crosslinking of lysine by polyamine oxidase or lysyl oxidase.
76 
Synthetic polypeptides are not limited to natural amino acids. To date, many non-
natural amino acids containing unique functional groups are reported. For example, 
alkene
78
 or alkyne-azido
79–83
 groups can be incorporated to polypeptides by NCA. 
Hydrogels can be obtained by crosslinking these groups with azide-alkyne 
cycloadditions thiol-ene reaction. 
1.2. Details of NCA Polymerization 
The first synthetic polypeptides were prepared by Curtius and Wessely in the 1920s. 
They showed that high molecular weight polypeptides can be prepared by ring-opening 
polymerization of NCAs, which is initiated by a nucleophile such as alcohol or a 
primary amine.
84
 Despite being well known, NCA polymerization has only gained its 
popularity in last two decades. The recent developments in NCA polymerization have 
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enabled the preparation of polypeptides with control over the molecular weight and the 
chain architecture. Additionally, self-assembling properties of polypeptides and their 
high biocompatibility have made them strong candidates for the next generation smart 
biomaterials.  
1.2.1. NCA Monomers: Synthesis and Purification 
The synthesis of NCAs via halogenating agents was firstly reported by Leuchs in 
1906.
85
 There have been many alternative ways proposed for the synthesis of -amino 
acid NCAs since then. One very efficient way is the Fuchs-Farthing method which 
utilizes phosgenation chemistry (Figure 1.4).
86
 Due to the high health risk of phosgene 
gas, its commercially available derivatives offer a safer and more practical usage. 
Liquid Diphosgene and solid triphosgene are easier to handle and store compared to 
phosgene gas.  
 
 
Figure 1.4. NCA synthesis by the Fuchs-Farthing method and phosgene derivatives. 
Phosgene free syntheses of NCAs have also been reported for specific amino acids. 
Recently, Endo and his group have shown that bisarylcarbonates can be used to 
convert amino acid into NCAs.
87
 The same group has also demonstrated that 
imidazolium salts of amino acids can be converted into NCA by using 
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phenylcarbonate.
88
 However, these methods do not apply to all amino acids easily 
and yields are lower compared to phosgenation. 
The syntheses of NCA monomers are always accompanied by side-products. 
Depending on the synthetic route these side products can be a mixture of HCl, 
aminoacid HCl salts, alkyl halides etc.
89
 Some of these side products may inhibit 
polymerization causing a lower degree of polymerization. Others may initiate 
polymerization causing low stability of the monomers or control over polymerization. 
Therefore, it is very important to remove by-products and prepare pure monomers for a 
controlled polymerization.  
Some side products can be removed by extraction and washing.
90
 Addition of -pinene 
to the reaction mixture scavenges HCl and related side product.
91
 However, further 
purification is always needed. Crystallization is the most common method for 
purification of NCA monomers. Multiple recrystallizations are crucial to achieving the 
desired purity. Depending on the amino acid and its protecting group, the number of 
recrystallization varies from two to six or more. In some cases, NCA monomer cannot 
be isolated as crystals. Especially, NCAs having lower melting points or long n-alkyl 
chains do not give crystalline products. In these cases, using silica gel column 
chromatography under dry and inert conditions may help for purification.
89
  
1.2.2 Mechanism of NCA polymerization 
NCA polymerization can be initiated by different methods. The most common 
methods to initiate NCA polymerization are the normal amine mechanism (NAM) and 
activated monomer mechanism (AMM). In NAM, a non-bulky nucleophile attacks the 
carbonyl of NCA to form a carbamic acid intermediate. Decarboxylation of this 
intermediate produces a primary amine which can propagate the polymerization 
(Figure 1.5). AMM starts by abstraction of H from N of the NCA ring by a non-
10 
 
nucleophilic base. Then, activated NCA initiates the polymerization in a similar 
manner to NAM. Amino acids with reactive side groups such lysine and tyrosine may 
initiate the polymerization. Therefore, protection of reactive groups must be done 
before NCA monomer synthesis.
 
 
Figure 1.5. The detailed mechanism of the N-Carboxyanhydride polymerization. 
An example of NCA in figure 1.6 shows the type of monomers, initiator, and removal 
of the protection groups.  
 
NAM 
AMM 
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Figure 1.6. NCA ROP of Z-Lysine and O-benzyl Tyr and removal of protection 
groups. 
1.2.3 Recent Methods and Developments in NCA-ROP 
When NCA polymerization is carried out under normal conditions (room temperature 
and atmospheric pressure), the control over the polymerization and the end group 
functionality is limited due to chain end termination by side reactions.
45,92,93
  
Deming developed transition metal initiators to prevent side reactions. Successful 
preparation of triblock copolypeptides having very high molecular weight (over 
200KDa) and low polydispersity (1.15) was achieved via initiation by cobalt, nickel 
and iron complexes such as bpyNi(COD), (PMe3)Fe, (PMe3)Co. Although the metal 
initiators needed to be removed after polymerization, this method provides excellent 
control over molecular weight, low dispersity, and high end-group functionality. 
44,94–96
  
In addition to transition metal complexes, optimization of reaction parameters in amine 
initiated polymerization also provides control over dispersity and end group 
functionality. Hadjichristidis and Messmann groups demonstrated that well-defined 
polypeptides with low dispersity can be obtained by highly pure monomers and high 
vacuum conditions.
47,97
 Vayaboury et al. showed that temperature dramatically affects 
the end group functionality. Interestingly, living end groups increased from 22% to 
99% by just decreasing the reaction temperature from 20
o
C to 0
o
C.
93 
The end group 
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termination was determined by non-aqueous capillary electrophoresis (NACE). It is 
found that dead chain ends have carboxylate and formyl groups (Figure 1.7). 
Formation of carboxylates was due to termination by an NCA anion (isocyanate 
resonance terminates amine ends). On the other hand, the formation of formyl end was 
due to the reaction with DMF.      
 
Figure 1.7. Living end group termination mechanisms.
93,98
 
For the synthesis of block polypeptides it is important to carry out polymerization at 
low temperatures because living end groups are critical to obtain satisfactory results. 
However, lowering the temperature increases the polymerization time from hours to 
several days. Heise and Habraken demonstrated that high vacuum and low temperature 
conditions are ideal for NCA polymerization. Removal of CO2 by vacuum shifts the 
CO2 - carbamic acid equilibrium to the right and this accelerates the polymerization.
45 
This condition provides control of NCA polymerization without metal complexes. 
Another way of initiating NCA polymerization utilizes hexamethyldisilazane (HMDS). 
Although HMDS is a secondary amine, the initiation and propagation steps are 
different than in the normal amine mechanism or activated monomer mechanism. 
Firstly, the trimethylsilane group is transferred to C2 of the NCA after the cleavage of 
the Si-N bond during initiation. Then, TMS amine reacts with NCA-TMS to form 
13 
 
TMS-carbamate. Finally, polymerization is propagated by transfer of TMS groups 
from previous TMS-carbamate monomer (Figure 1.8).
98
       
 
Figure 1.8. Mechanism of HMDS initiated NCA-ROP.
98
 
1.3. Triazolinedione (TAD) Chemistry 
1.3.1 Synthesis of TADs 
Triaziolinediones are one of the most reactive dienophiles and enophiles ever known
99
. 
The first reports on syntheses of TADs via the oxidation of 4-phenylurazole were 
given by Thiele in 1894 and by Stolle in 1912
100
. However, both reported only low 
yields. Cookson’s work in 1962100 and 1967101 is considered to be a milestone in TAD 
syntheses where he achieved high yields and demonstrated Diels-Alder reaction with  
4-Phenyl-3H-1,2,4-triazole-3,5(4H)-dione (PTAD).
102
 In the 1980s and 1990s, simple 
TADs such as PTAD, Methyl-TAD were used to modify and crosslink polymers to 
alter mechanical or optical properties of materials. Additionally, bisTADs were 
reported to be used in step-growth polymerization.
99,103–105
 TAD chemistry has 
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regained attention in this millennium due to the improvements in its synthesis
106,107
 and 
the success in applications such as total synthesis
108
, bioconjugation
109,110
, polymer 
chemistry and material chemistry
111–116
. Du Prez and co-workers has reported an 
extensive review on TADs which includes its history, synthesis (precursor and 
oxidation), reactivity and applications in polymer and material science.
102
  
In general, TADs are synthesized from their corresponding urazoles via oxidation. 
Urazoles can be synthesized from amines, anilines, isocyanates and carboxylic acids in 
two or three steps (Figure 1.9). Little et al. reported 100 g scale urazole synthesis from 
these precursors.
106
 The first step of urazole synthesis is the formation of 
semicarbazide (1) or sometimes referred as hydrazinecarboxylate. Then, urazole (2) 
forms upon cyclization of 1 in strong basing conditions such as refluxing in 4N KOH 
or K2CO3/EtOH. 
 
Figure 1.9. Urazole synthesis 
The final step in TAD synthesis, the oxidation of urazole, is the most challenging step. 
There are numerous methods proposed, especially by Mallakpour, to oxidize urazoles 
to the corresponding TADs.
107,117–122
 Du Prez classified the oxidizing agents for TAD 
15 
 
synthesis as nitrogen(IV) & nitrogen(V) oxide-based, halogen-mediated, activated 
DMSO & selenic acid-mediated, metal ion/metal oxide-mediated, electrochemical 
oxidation and others.
102
 The choice of oxidizing agent should be guided by the urazole 
structures. A mild oxidizing agent is more suitable for urazoles having oxidizable 
functional groups. Additionally, it is important to test different classes of oxidizing 
agents to obtain TADs in satisfactory yield and purity. 
 
Figure 1.10. Final step in TAD synthesis. 
Commercially available oxidizing agents such as 1,3-dibromo-5,5-dimethylhydantoin 
or 1,3-dichloro-5,5-dimethylhydantoin can be used as a convenient option.
119
 
However, removal of hydantion related side products presents a challenge. 
Additionally, this method produces hydrogen halides (4 equivalent of HX per urazole). 
For some applications such as gel formation, these side products can be washed off 
after crosslinking. Therefore, side products might not be a problem. On the other hand, 
if a pure TAD is needed, alternative methods should be chosen because the purification 
might be very challenging due to the high reactivity of TADs. Heterogeneous 
oxidizing agents are promising to obtain pure TADs. Silica-bound nitric acid was 
shown to be effective and it can be removed by filtration. However, water coming of 
nitric acid may decompose TAD if the oxidation is done in a hygroscopic solvent. For 
other solvent, drying solution with anhydrous MgSO4 just after oxidation gives good 
results. Otherwise, water decomposes TAD especially when water gets concentrated 
during evaporation of the organic solvent. 
16 
 
 
1.3.2 Novel TAD Compounds  
Previously, simple TADs such as PTAD or Mehtyl-TAD (and their bifunctional 
counterparts) were used in polymer modifications. Recent developments in TAD 
synthesis and demonstration of click-like behaviour has attracted scientist to synthesize 
new TAD compounds with more exotic functionalities. The reactivity and stability of 
the new compounds may differ depending on adjacent groups of TAD moiety. Some 
TADs can be isolated and stored for months but others may require in-situ preparation 
and immediate use. Additionally, incompatibility of the oxidation method may lower 
their stability. 
Some of the recently reported TADs are shown in Figure 1.11. Azide (1) and alkyne 
(2,3) TADs were used in the bioconjugation of tyrosine.
110,123,124
 Urazole precursors of 
2 and 3 were reacted with PEG-azide and then oxidized to form pseudo PEG-TAD. 
The PEGylation of chymotrypsinogen (a digestive enzyme) and aplaviroc (anti-HIV 
drug) was done by using pseudo PEG-TAD. The PEGylation is an important reaction 
in pharmaceutical applications and this method is more convenient (due to its click-
like character) than previously reported PEGylation of tyrosine.
125
 However, the 
reported pseudo PEG-TAD requires tedious synthesis of 2 and 3 and was not isolated 
and characterized after reaction of 2,3 with PEG-azide.  
17 
 
 
 
Figure 1.11 Some of the recently reported TAD compounds. 
ATRP-TAD (4) compound was reported by Du Prez and co-workers.
111
 Later this 
initiator was used to create rewritable polymer brushes (Figure 1.12)
112
. Indole-
functionalized glass or silicon surfaces were prepared by the thiol-ene reaction. Then 
PDMS stamp having the initiator was printed on this surface by reversible TAD-indole 
click reaction. Patterned polymer brushes were grown by surface-induced ATRP and 
these brushes were erased at high temperature due to reversible nature of the 
18 
 
reaction
108
. The re-writing was done with the same cycle and this process was repeated 
4 times to demonstrate the robustness of the method.  
 
Figure 1.12. Rewritable surfaces by using reversible TAD-indole reaction.
112
 
 
and Curran.
126
  Fluorous TAD (5) was used to scavenge excess dienes after Diels-
Alder reaction (Figure 1.13). Due to its high reactivity and distinct color, scavenging 
reactions can be done in seconds and monitored by the naked eye. Scavenged dienes 
can be removed by solid-phase extraction on fluorous silica gel (FSPE). 
 
Figure.1.13. Scavenging dienes by fluorus TAD and purification by FSPE. 
Commercially available DMEQ-TAD (described in Chapter 4) and TAD-Ferrocene (6) 
was used to tag vitamin D. Then, quantification of vitamin D metabolites was done by 
19 
 
fluorescence spectroscopic methods (for DMEQ)
127
 and by mass spectrometry (for 
ferrocene).
128
 Jessica et al. demonstrated that novel [18F]-4-(4-fluorophenyl)-1,2,4-
triazole-3,5-dione (7) can be used to radiolabel tyrosine on short peptides and proteins. 
This agent has potential to be used in positron emission tomography (PET) imaging    
In chapter 4, we report the synthesis and use of mono and bifunctional PEG-TAD (8, 
9) which are directly synthesized from PEG-amine, isolated as powder and 
characterized by NMR and IR. Additionally, synthesis and characterization of ester-
TAD (10) and carboxylic acid TAD (11) are reported in Chapter 3. 
1.4. Aim of the work 
The main aim of the project is the synthesis of polypeptide-based hydrogels which 
may find application in tissue engineering, drug delivery and related fields. The 
approach follows three steps. The first step involves the synthesis of polypeptides by 
NCA polymerization. Secondly, TAD crosslinkers are synthesized. Finally, the 
polypeptides are crosslinked to obtain hydrogels. The project is designed to crosslink 
natural amino acids by a fast, efficient and selective reaction. For this reason, TAD-
tyrosine and TAD-tryptophan reactions were examined and utilized. Details are 
described in the following chapters 3-5, which have been drafted for publications.  
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Chapter 2 
Enzymatic Crosslinking of Polypeptides  
Abstract 
Horse-radish peroxidase (HRP) and some other enzymes such as myeloperoxidase can 
convert tyrosine to tyrosyl radical. Reactive tyrosyl radicals combine with each other 
to form dityrosine and so to crosslink proteins. We have explored this concept for 
synthetic copolypeptides where the amount of tyrosine, polypeptide length and 
architecture can be varied. Firstly, tyrosine NCA and other amino acid NCAs were 
prepared by Fuchs-Farthing method. Then, these monomers were polymerized by 
hexylamine initiator to obtain statistical and block polypeptides. SEC results showed 
narrow distribution of polypeptides. Finally, these polypeptides were used in gelation 
trials. In total, 17 different polypeptides have been tested approximately 45 different 
conditions each. Concentration of the polypeptide, amount of HRP enzyme and H2O2 
were varied systematically. However, none of the conditions resulted in gelation.  
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2.1 Introduction 
Peptides derived from natural sources present two challenges. Firstly, their 
composition varies depending on the source and secondly, synthetic modification is 
largely limited to side chain modification of the amino acids. On the other hand, NCA 
polymerization allows researchers to create polypeptides with different lengths, 
composition and architectures such as random, block or star polymers. Despite being 
synthetic, the repeating units of NCA polymerization can be completely made of 
natural amino acids such as glutamic acid, lysine or tyrosine. Additionally, non-natural 
functional amino acids can also be copolymerized with natural amino acids to widen 
the scope of the synthetic pathways for functionalization and crosslinking.
1
 Natural 
peptides can be covalently crosslinked using chemical coupling agents
2,3
  
photocrosslinking
4–8
 or simple physically crosslinked through chain interaction
9–17
.  In 
this chapter, we set out to form hydrogel polypeptides by covalent crosslinking. In 
order to avoid harsh chemicals, we took inspiration from crosslinking reported on 
natural peptides using specific enzyme. There are several enzymes catalyzing reactions 
between a pair of the same or different amino acids to form dimers. These kind of 
enzymes can be used as crosslinking enzyme.
18–24
 For example, transglutaminase 
catalyzes the reaction between lysine and glutamine forming a crosslinked network of 
gelatin
25,26
, short peptide sequences
23
 or PEG-peptide hybrids
27
 (Figure 2.1).
 
Horse-
radish peroxidase and myeloperoxidase enzymes have been shown to crosslink 
tyrosine via tyrosyl radical formation (Figure 2.2).
20,21,27–32
 We hypothesized that the 
enzymatic crosslinking reaction can be applied to synthetic polypeptides.  
Whereas, tyrosinase enzyme oxidizes tyrosine to benzoquinone and this can be 
exploited to crosslink with amines.
28
  Lehrer and Fasman showed that the major 
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product of the photooxidation of tyrosine (where tyrosyl radical is createad) is o,o’-
diytrosine (Figure 2.2).
33
  
 
Figure 2.1 Transglutaminase enzyme crosslinked PEG glutamine with lysine 
containing polypeptide.
27 
 
Figure 2.2 Resonance structures of tyrosyl radical. Major product of radical coupling 
is o-o-dityrosine.
33 
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2.2 Results and Discussion 
Inspired by the successful reports in the literature, we aimed to crosslink tyrosine 
containing polypeptides by HRP. For this purpose, we prepared a library of random 
and block copolypeptides as well as hybrid block copolymers by NCA polymerization 
(Table 2.1). As monomers benzyl-L-glutamate (BLB), Carbobenzyloxy-L-lysine 
(ZLL) and O-benzyl-tyrosine NCA (OBT) were synthesized according to literature 
procedures. The NMR and FTIR spectra were in agreement with the structures as 
shown in Figure 2.3 and 2.4 for OBT NCA. Ring formation can be seen in 
1
H-NMR 
from the proton at 4.4 ppm (Figure 2.3), while carbonyls of the NCA ring can be seen 
at 1845 cm
-1
 and 1773 cm
-1 
in IR spectrum (Figure 2.5). 
 
Figure 2.3. NMR spectrum of O-benzyl-tyrosine NCA in chloroform-d. 
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Figure 2.4. IR spectrum of O-benzyl tyrosine NCA (neat). Carbonyl peaks of NCA are 
at 1845cm
-1
 and 1773cm
-1
. 
 
Figure 2.5. IR spectrum of poly(lys-st-tyr) (neat). 
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2.2.1 Tyrosine Containing Polypeptides 
Three different groups of polypeptides were prepared. PEG hybrids were prepared by 
using commercially available PEG mono amines and diamines as initiators. BLB and 
ZLL containing copolypeptides (statistical and block) were prepared by 
copolymerization with OBT. Each group of polypeptides was deprotected to obtain 
main functional groups, phenol of OBT, amine of ZLL and carboxylic acid of BLB. 
The water insoluble polypeptides become water soluble after deprotection. Removal of 
protection groups was confirmed by 
1
H-NMR spectroscopy by examining the aromatic 
region peaks.   
Table 2.1 Summary of synthesized polymers and gelation trials. GPC results for the 
glutamic acid containing polymers were not added because their data were not reliable.   
 
PEG: Polyethylene Glycol     Tyr: Tyrosine     Gla: Glutamic acid   Lys: Lysine 
Statistical copolypeptides were synthesized under vacuum at room temperature 
whereas block copolypeptides were obtained under vacuum at 0
o
C. For block 
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polypeptides, the second monomer was added after the consumption of the first 
monomer which was monitored by IR. 
 
Figure 2.6. GPC chromatogram of  lysine containing block copolypeptides (12,13 and 
14 from table 1) 
2.2.2 Gelation Trials 
To test gelation we firstly started with the similar conditions (concentration of 
polymer, amount of phenol, HRP and H2O2 etc.) as reported in literature examples. 
Then, we varied reaction parameters independently. However, none of the 17 polymers 
representing many different conditions resulted in gelation. Additionally, no molecular 
weight change in GPC for the ones soluble in the eluent (#1 and #2) was detected. 
Unfortunately, we were not able to monitor molecular weight change for all 
deprotected polypeptides due to their insolubility in SEC solvents (THF & DMF). A 
couple of fresh batches of HRP enzymes with different types are also tested. The result 
showed that the tyrosyl radical either does not form or it reacts in different ways not 
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leading to dityrosine formation. In conclusion, no gelation was observed and no further 
investigation was done.   
Table 2.2. Some conditions to test crosslinking Tyr6-PEG3K-Tyr6.
 
2.3 Experimental 
Materials: Chemicals and reagents: All reagents were purchased from Sigma-Aldrich 
unless otherwise noted. Protected amino acids were purchased from BACHEM. 
Triphosgene was purchased from Fluorochem and freshly used. Snake skin dialysis 
tubing (3.5K MWCO) was obtained from VWR. Silica nitric acid was prepared as 
described in literature.1 Tris buffer solution was prepared using Trizma® base. Ethyl 
acetate over moleculer sieves  were purchased from Across-Organics . 
Methods: 
1
H and 
13
C NMR spectra were recorded at room temperature with a Bruker 
Avance 400 (400 MHz).  ATR-FTIR spectra were collected on a Perkin Elmer 
Spectrum 100 in the spectral region of 650-4000 cm-1, and were obtained from 16 
scans with a resolution of 2 cm-1. Background measurements were taken before each 
analysis.SEC analyses of the protected polypeptides were done using Agilent GPC 
running on DMF with dn/dc value set to 1.599. 
NCA setup: An ideal NCA reaction setup is shown in Figure 2.7. Since NCA is 
moisture sensitive, all the system should be kept under constant flow of Nitrogen.  One 
end of the system is open to prevent excess pressure and possible explosion due to this 
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pressure. Additonally, open end of the system is connected to NaOH trap to neutralize 
HCl (product of the reaction) and possible phosgene gas which is extremely toxic. 
 
Figure 2.7. Main setup of the NCA polymerization. 
Synthesis of O-benzyl-L-tyrosine NCA: 10.0 g (36.9 mmol) of O-benzyl-L-tyrosine 
placed into oven dried three-neck round-bottomed flask. Then, 80 ml of anhydrous 
ethyl acetate and 15g (17.5mL, 110mmol) α-pinene added while keeping flask flushed 
with low flow of N2. The suspension heated to reflux temperature with keeping N2 
flow continues for whole reaction. 5.5g (18.4 mmol) of triphosgene dissolved in 40mL 
anhydrous ethyl acetate and added to the suspension dropwise using dropping funnel. 
Two-thirds of the triphosgene solution was added within approximately 1 hour. Then, 
addition of triphosgene was stopped for another hour. The remaining triphosgene 
solution was added dropwise and suspension became clear solution after 2-3 hours. 
Then, solution was concentrated to approximately half volume by using rotavap. 
Concentrated solution was precipitated into 150 mL anhydrous heptane. The mixture 
was kept overnight at -20 for complete crystallization. Then, mixture was brought to 
room temperature and the solid were collected by vacuum filtration. Solid was 
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recrystallized four times with 1:2 ethyl acetate:heptane. The final product was white 
needle shape crystals. Isolated yield: 7.54g , 69% 
Synthesis of Lys(Z) NCA: 7g of Lys(Z)-OH were put into oven dried 250mL three 
neck round bottom flask under constant slow flow of nitrogen. Then 120mL anhydrous 
ethylacetate added together with 7.5g (8.7mL) a-pinene. The rest of the procedure was 
same with tyrosine NCA until crsytallization step. Unlike tyrosine NCA, Lysine NCA 
tends to form wet cake during reaction but it turns into mixable suspension after 1-2 
hours and a clear solution after 3-5 hours. The crude was recrystallized two times with 
1:1 Ethyl acetate/Heptane mixture. The final product was white fine powder. Isolated 
yield: 6.3g, 82% 
Synthesis of y-Benzyl-l-glutamate NCA: 10g (42.1 mmol) y-benzyl-l-glutamate were 
put into oven dried 250Ml round bottom flask under constant slow flow of nitrogen. 
Then 80mL anhydrous ethylacetate added together with 10.4g (12.1mL) a-pinene. The 
rest of the procedure was same with lysine NCA except that the amount of triphosgene 
was 6.2g. The crude was recrystallized two times with 1:1 Ethyl acetate/Heptane 
mixture. The final product was a fluffy white fine solid. Isolated yield: 7.8g, 70,2% 
Polymerizations: Hexylamine is used to initiate all polymerizations in this chapter. 
The repeating units were set by using mol numbers. For synthesizing 20 repeating 
units (theoretical) polypeptide from, 1g BLG NCA (3.8mmol-20 eq) the amount of  
hexylamine was set to 0.19 mmol -1eq. Since the amount of initiator is too small to 
handle, a 50-fold less concentrated stock solution of initiator was used. An exact 
procedure for poly(BLB40-st-OBT6) or the entry 9 in table 2.1 is given below. 
Synthesis of poly(ZLL40-st-OBT10): 1040 Mg of ZLL-NCA (3.40 mmol) and 252 mg 
of OBT-NCA (0.85 mmol) were dissolved in 20mL anhydrous DMF under inert 
atmosphere. The solution was purged with N2 for 10 minutes. Then, hexylamine (9mg, 
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0.085 mmol) from stock solution was added fast and moderate vacuum applied. After, 
5-6 hours the solution was precipitated into diethyl ether and collected by vacuum 
filtration. Finally, the product was washed and dried under vacuum. Yield: 972 mg, 
88% , NMR shown in figure 2.8.  
 
Figure 2.8. 
1
H-NMR spectrum of poly(ZLL40-st-OBT10) in TFA-d. 
Synthesis of statistical copolymers: The monomers were placed into a oven dried 
schlenk tube. 7 mL of anhydrous DMF was added for each 1g of monomer (e.g. 21mL 
DMF for 3 g of monomer mixture). The solution was purged with N2 for 10 minutes. 
The initiator was added one time and fast while stirring fast at room temperature. Line 
vacuum was applied until the end of reaction. The monomer consumption progress 
was monitored by IR (NCA carbonyls (near 1850cm
-1
 and 1760cm
-1
) should disappear 
completely. Generally, the majority of the monomers were consumed in 3-4 hours at 
room temperature. Then the solution was precipitated into diethyl ether. Product was 
collected by filtration. DMF was not completely removed even washing with excess 
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diethyl ether for lysine containing polypeptides. Therefore, these polypeptides were 
dissolved in chloroform and precipitated in diethyl ether. The process repeated until no 
more DMF peak was seen in NMR. The solids were collected by filtration and dried in 
vacuum oven. The yield of the polymerization was generally over 95%.   
Synthesis of block copolymers: The first monomer was placed into schelenk tube and 
anhydrous DMF was added (7mL for 1g of monomer). The solution was purged with 
N2 for 10 minutes while cooling solution to 0
o
C. The initiator was added one time and 
fast while stirring solution at 0
o
C. The consumption of the first monomer was followed 
by IR. Generally, it took 2 days for NCA peaks to disappear on IR indicating majority 
of the monomers were consumed. Then, second monomer was dissolved in anhydrous 
DMF and added to the polypeptide solution. The consumption of the second monomer 
was also followed by IR. The resulting solution was precipitated into diethyl ether. The 
rest of the work up was same with statistical copolymers. The yield of the 
polymerization was generally over 95%.    
Synthesis of PEG polypeptide hybrids: The first monomer was placed into schelenk 
tube and anhydrous DMF was added (7mL for 1g of monomer). The solution was 
purged with N2 for 10 minutes. PEG-amine or PEG-diamine were dissolved in separate 
flask in DMF (1mL for 0.1g of PEG) and purged with N2 for 10 minutes. Then PEG 
solution was added into the monomer solution in one time and fast while stirring the 
monomer solution. The monomer consumption followed by IR and polypeptide 
solution was precipitated into diethyl ether. The resulting solid was washed with 
excess diethyl ether and dried under vacuum oven. The solids were collected by 
filtration and dried in vacuum oven. The isolated yields of the polymerization were 
generally over 87%.  
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Deprotection of the polypeptides: In general, 500mg (approximately 1 equivalent of 
monomer) of polypeptide dissolved in approximately 5 mL of trifluoroacetic acid. To 
this solution approximately 1.5 mL HBr (3-4 equivalent) in acetic acid is added 
slowly. After 4-16h the solution precipitated in diethyl ether and the solid was washed 
with excess diethyl ether. The resulting solid was dried and dissolved in deionized 
water. Finally, the solution is placed into 3.5MWCO snake skin dialysis bag and 
dialyzed for 3-4 days by refreshing dialysis water 4 times a day. An exact procedure is 
given below; 
Synthesis of poly(Lysine40-st-Tyrosine10): 600mg of poly(ZLL40-st-OBT10) was 
dissolved in 12 mL trifluoroacetic acid. 3mL of HBr (33% in acetic acid) was added 
dropwise and solution stirred. After 4 hours, the mixture was precipitated into diethyl 
ether. Then, product was washed and collected by vacuum filtration. The dried 
polypeptide was dissolved in deionized water and placed into 3.5 MWCO snake skin 
dialysis bag and dialyzed for 3-4 days by refreshing water 4 times a day. Finally, white 
fluffy product was obtained after freeze-drying. Yield: 445mg. 
 
Figure 2.9 
1
H-NMR spectrum of poly(Lysine40-st-Tyrosine10) in D2O. 
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Gelation trials: Approximately 45-50 conditions were tested for each polypeptide. 
Basically, the concentration of the polymer, amount of HRP, H2O2 and temperature 
were varied. Some conditions were shown in table 2-2 to give some insight about the 
orders of the magnitude. 
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 Chapter 3 
 TAD-Tyrosine Functionalization  
Abstract 
Highly efficient functionalization and cross-linking of polypeptides was achieved via 
tyrosine-triazolinedione (TAD) conjugation chemistry. The feasibility of the reaction is 
demonstrated by the reaction of 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD) with 
tyrosine containing block copolymer PEG-Tyr as well as a random copolymer of 
tyrosine and lysine (poly(Lys40-st-Tyr10)) prepared form N-carboxyanhydride (NCA) 
polymerisation. Selective reaction of PTAD with the tyrosine units was obtained 
verified by Size-Exclusion Chromatography (SEC) and NMR spectroscopy. Moreover, 
two monofunctional and two difunctional TAD molecules were synthesized. It was 
found that their stability in the aqueous reaction media significantly varied. Under 
optimized reaction conditions selective functionalization and cross-linking, yielding 
polypeptide hydrogels, could be achieved. TAD-mediated conjugation could offer an 
interesting addition in the toolbox of selective (click-like) polypeptide conjugation 
methodologies for NCA polymerization as it does not require functional non-natural 
amino acids. 
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3.1 Introduction 
Synthetic polypeptides derived from the polymerisation of amino acid N-
carboxyanhydrides (NCA) are highly promising biomimetic materials for biomedical 
applications.
1, 2
  Advanced polymerisation techniques in tandem with recently 
developed orthogonal functionalization approaches  have enabled a large structural and 
functional diversity with the potential to design bespoke polypeptide biomaterials.
3, 4
  
Lately, researchers focused on the facile orthogonal functionalization of synthetic 
polypeptides by ‘click’ chemistry, for example azide-alkyne5-8 , thiol-ene9 (click-like)  
and thiol-yne
10, 11
  reactions. While these techniques are highly efficient, selective and 
readily applicable for synthetic polypeptides, all of them require special non-natural 
amino acid monomers. Numerous strategies have also been devised for the 
functionalization of natural amino acids in polypeptides, for example of lysine, 
glutamic acid and cysteine.
12, 13
  However, these reactions lack the selectivity and 
efficiency of ‘click’ chemistry.  
We are interested in developing routes for the selective functionalization and cross-
linking of synthetic polypeptides by ‘click’-like chemistry on natural amino acids and 
identified tyrosine as a potential candidate. There have been several reports on the 
selective modification of tyrosine, such as Mannich-type reactions, conjugation via 
diazonium salts or cyclic imines, among others.
14-17
 Haddleton and co-workers 
reported the first time of PEGylation of tyrosine by using diazonium salt-terminated 
PEGs (Figure 3.1). Unfortunately, all these techniques have certain limitations: 
Mannich-type reactions are relatively slow, diazonium salts have poor selectivity 
(unless carried out at a defined and narrow pH range) and cyclic imines have low 
yields.  
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Figure 3.1. Tyrosine functionalization by Mannich-type reaction, cyclic imines and 
diazonium salt coupling, (top to bottom)
14-17
. 
Recently Ban et. al. reported a click-like reaction for tyrosine, which uses a class of 
cyclic azodicarbonyl compounds such as 4-phenyl-1,2,4-triazoline-3,5-dione 
(PTAD).
18, 19
 The authors demonstrated that conjugation is fast, selective and efficient 
on short amino acid sequences as well as larger natural proteins, and can be combined 
with other conjugation techniques (Figure 3.2).      
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Figure 3.2. Click-like tyrosine conjugation by TAD. 
 
The latter was effectively utilized by Hu to prepare well-defined glycoconjugated 
vaccine for treatment of candidiasis.
20, 21
  The synthetic strategy involved the 
alkynylation of tyrosine units of the nontoxic mutant diphtheria toxin CRM197, a 
protein carrier in many licensed vaccines, via protein 1,2,4-triazoline-3,5-dione (TAD) 
chemistry followed by the attachment of glucan chain onto it via azide-alkyne click 
chemistry. They also showed that use of tris buffer can scavenge isocyanate 
decomposition product of TAD
22
 which lowers the selectivity. TAD functionalization 
was also recently used to radiolabel tyrosine of natural proteins using [18F]4-(4-
fluorophenyl)-1,2,4-triazole-3,5-dione.
23
  In another example, Bauer et. al. prepared 
bifunctional TAD linkers and showed protein-DNA conjugation (Figure 3.3).
24
   
 
Figure 3.3. Preparation of protein DNA conjugates by bifunctional TAD linkers.
24 
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TAD chemistry was also recently exploited in fully synthetic polyacrylates by Du Prez 
et. al. to enable ultrafast reversible click reaction with indole groups to create dynamic 
polymer networks.
25, 26
 Very recently, Nakamura and coworkers have published a 
method for tyrosine-specific modification. They modified bovine serum albumin using 
in situ activated luminol derivative under under oxidative conditions (Figure 3.4).
27
  
 
Figure 3.4. Tyrosine functionalization by Luminol derivatives. 
 
 
 
 
 
 
 
 
 
52 
 
3.2 Results and Discussion 
Inspired by these reports we have explored the TAD-tyrosine reaction for the 
conjugation and cross-linking of synthetic polypeptides. A specific focus was on the 
demonstration of the selectivity in the presence of an excess lysine in the polypeptide. 
Lysine is a facile monomer to introduce hydrophilicity and cationic charges for the 
preparation of hydrogels and complexation of pharmacologically active nucleic acids 
(e.g. RNA).
28-30
 
3.2.1 Testing TAD-Tyrosine reaction 
In order to demonstrate the versatility of the reaction, PTAD conjugation was first 
carried out on a poly(ethylene glycol) (PEG)-Tyr block copolymer. This model system 
was selected as the PEG chain improves the polypeptide solubility in organic solvents 
permitting convenient reaction analysis. Amine functional PEG (5000 g/mol) was used 
to initiate the polymerisation of benzyl-L-Tyr NCA targeting an average of 3-4 
tyrosine units.
31
 A clear increase in molecular weight was apparent in Size Exclusion 
Chromatography (SEC) analysis upon macroinitiation (Figure 3.5). Quantitative 
deprotection of the benzyl ether groups in TFA/HBr/acetic acid yielded the PEG-Tyr4 
block copolymer confirmed by 
1
H NMR spectroscopy. Initially, conjugation with 
commercially available PTAD was tested in acetonitrile/Tris buffer 1:1 mixture 
(Figure 3.5). The reaction was monitored by the change of PTAD’s distinct red colour. 
Firstly, the colour turned into maroon, followed by brown, orange and finally pale 
yellow during the reaction. PTAD conjugation to the block copolymer took around 1.5 
hours with a functionalization yield of about 83%. The increase in molecular weight 
after PTAD conjugation is clearly evident in the SEC traces (Figure 3.5).  
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Figure 3.5. SEC chromatograms of PEG-amine (5000 g/mol), PEG-Tyr5 block 
copolymer before and after PTAD functionalization. 
3.2.2 Selectivity of the TAD-Tyrosine reaction 
To further test the selectivity of tyrosine ligation, a statistical copolymer of ZLL-lysine 
and benzyl-L-tyrosine (4:1) was prepared using hexylamine as initiator (Scheme 1). 
SEC of the copolymer resulted in a Mw of 11,500 g/mol (dispersity index, Đ=1.1). 
Subsequent quantitative deprotection of the polypeptide, monitored by 
1
H NMR 
spectroscopy (Figure 3.6), in TFA/HBr/acetic acid yielded poly(Lys40-st-Tyr10). 
Conjugation with PTAD was carried out in acetonitrile/Tris buffer 1:1 mixture and the 
distinct colour change was observed during the reaction. PTAD functionalization of 
poly(lys40-st-tyr10) took approximately 7-8 minutes for 25 mg/mL polymer 
concentration and a feed ratio Tyr/PTAD of 1.2. From 
1
H NMR spectra it was 
calculated that at least 85% of the tyrosine units in the copolymer were functionalized 
with PTAD (Figure 3.6). No evidence of PTAD reacting with lysine was seen in 
1
H-
NMR spectrum. 
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Figure 3.6. 
1
H-NMR spectrum of poly(Lys40-st-Tyr10) (at bottom) and after PTAD 
conjugation (top) in D2O. 
The results obtained with the model compound PTAD highlight the ability to 
selectively functionalise tyrosine units by TAD chemistry in the presence of an excess 
of lysine. While the reaction was not quantitative under the tested conditions, it should 
allow the formation of cross-linked polypeptides and hydrogels.  
3.2.3 Functionalization of Tyrosine with other TADs 
A series of four mono and difunctional TAD molecules (figure 3.7) were investigated 
in the cross-linking of poly(lys40-st-tyr10). The precursors of difunctional TAD 
compounds were prepared from the corresponding diisocyanates as described in 
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literature. Firstly, hydrazine carboxylates of each compound were prepared by reaction 
of corresponding isocyanate with ethyl carbazate. Then, urazole ring formation was 
achieved under basic aqueous conditions or ethanol/K2CO3.
 
For the final oxidation step 
from urazole to TAD two different methods were employed. Firstly, commercially 
available 1,3-dibromo-5,5-dimethylhydantoin (DBMH) was used in acetonitrile. 
During the process the insoluble urazole compounds became soluble and gave 
characteristic red colour. However, the product contained two side products, i.e. HBr 
and dimethyl hyndantoin. We observed that the presence of HBr in the subsequent 
conjugation step had a negative effect on the reaction yield. Reduced yields at low pH 
was also reported by Ban.
18
 Additionally, the presence of acid may cause polypeptide 
hydrolysis. Neutralizing the HBr in a basic workup resulted in immediate 
decomposition of the product. Alternatively, urazole compounds were oxidized to the 
corresponding TADs by using silica supported nitric acid, which gave cleaner products 
in good yields. By this method all TAD derivatives 1-4 were successfully obtained as 
confirmed by 
1
H NMR spectroscopy yet their stability significantly varied. 
 
Figure 3.7. TAD derivatives for functionalization and crosslinking. 
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MDP-TAD (2) was obtained as a red powder but turn into brown within 1-2 hours 
indicating that oxidation method was not compatible with the compound. Crosslinking 
trials with 2 failed and resulted in a brown precipitate in acetonitrile/tris (1:1) 
conditions. HM-bisTAD (3), benzoate and benzoic acid TAD derivatives were stable 
as powders. However, 4-ethyl benzoate TAD (1) and TAD benzoic acid (4) 
immediately decomposed in 1:1 acetonitrile/Tris buffer conditions. Lowering the 
aqueous ratio of the mixture retarded the decomposition and conjugation yields of 30% 
with benzoate TAD and up to 81% with TAD-Benzoic acid in DMF/tris buffer (9:1) 
was achieved. These results underline that the success of TAD-Tyr functionalization 
depends on the stability of TAD in the aqueous mixture. 
               
Figure 3.8. Poly(lys-ran-tyr) hydrogel crosslinked by HM-TAD. 
 
The difunctional HM-bisTAD reacted well with poly(lys40-st-tyr10). Cross-linking of 
the polymer and formation of a stable hydrogel occurred in less than 2 min. at room 
temperature. When HM-bisTAD was added to the polypeptide solution it resulted in 
phase separation because of hydrophobic nature of HM-TAD. After 1 min. of stirring 
the reaction mixture became viscous and the hydrogel formed as evident from the vial 
tilting method (Figure 3.8). Unreacted HM-bisTAD could be washed out by THF and 
the previously pale yellow hydrogel became completely clear. Swelling test were done 
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after freeze drying of the hydrogel. The hydrogel is capable of absorbing 38 times its 
own weight i.e. 97,43% of the material is water. 
3.2.4 Orthogonal Functionalization of Lysine and Tyrosine 
We have tested the orthogonal functionalization of tyrosine and lysine with TAD and a 
sugar. Firstly, we modified Poly(lys-ran-tyr) with PTAD and then sugar (Figure 3.9). 
We succesfully functionalized both with this order. Then we reverse the 
functionalization order. In this case, sugar functionalized Poly(lys-ran-tyr) was not 
soluble anymore in ideal PTAD functionalization conditions. Therefore, we have tried 
non ideal conditions where tris buffer was missing. We saw that PTAD was 
decomposed and reacted with other groups (probably OH of sugar). Finally, we solved 
the problem by partial functionalization of lysine in which Poly(lys-ran-tyr) was 
soluble in ideal PTAD conjugaton conditions (1:1 Acetonitrile/Tris Buffer).  
 
Figure 3.9. Orthogonal functionalization of tyrosine and lysine with PTAD and D-(+)-
gluconic acid δ-lactone. 
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3.3 Experimental 
Materials: Chemicals and reagents: All reagents were purchased from Sigma-Aldrich 
unless otherwise noted. Protected amino acids were purchased from BACHEM. 
Triphosgene was purchased from Fluorochem and freshly used. Snake skin dialysis 
tubing (3.5K MWCO) was obtained from VWR. Silica nitric acid was prepared as 
described in literature. Tris buffer solution was prepared using Trizma® base. Ethyl 
acetate over moleculer sieves were purchased from Across-Organics . 
Methods: 
1
H and 
13
C NMR spectra were recorded at room temperature with a Bruker 
Avance  
400 (400 MHz).  ATR-FTIR spectra were collected on a Perkin Elmer Spectrum 100 
in the spectral region of 650-4000 cm
-1
, were obtained from 16 scans with a resolution 
of 2 cm
-1
. Background measurements were taken before each analysis.SEC analyses of 
the protected polypeptides were done using Agilent GPC running on DMF with dn/dc 
value set to 1.599. 
Synthesis of poly(Z-Lys40-st-O-benzyl-Tyr10): 1090 mg (3.56mmol) Lysine NCA 
and 267mg (0.89mmol) of tyrosine NCA were dissolved in 10 mL anhydrous DMF 
and the solution was purged with nitrogen for 10 minutes. 9 mg Hexylamine (1.8 mL 
of 50mg/ml stock solution in DMF – 0.089 mmol) was added fast to the solution and 
stirred at room temperature. The reaction was monitored by IR spectroscopy until all 
monomer was consumed (6-8 hours). Then the polypeptide solution was precipitated 
dropwise into 200 mL diethyl ether. After decanting the solvent, fresh diethyl ether 
was added and stirred for 20 min and repeated one more time. The product was then 
collected and dried under vacuum. Isolated Yield: 1075mg, 93%. 
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Figure 3.10. NMR spectrum of poly(Z-Lys40-st-O-benzyl-Tyr10) in TFA-d. 
 
Figure 3.11. GPC chromatogram of poly(Z-Lys40-st-O-benzyl-Tyr10) 
 
Synthesis of poly(Lys40-st-Tyr10): 600 mg of protected polymer was dissolved in 5-6 
ml trifluoroacetic acid. To this solution, 0.5 mL of HBr (33% in acetic acid) solution 
was added dropwise and stirred overnight. Then the solution was precipitated in 100 
mL diethyl ether. After the product was collected, it was washed with an excess diethyl 
ether and dried under vacuum. The dried polymer was dissolved in water and placed 
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into a 3.5 MWCO snake skin dialysis tubing and dialyzed against water for 3 days 
(refreshing water 4-5 times a day). Finally, solution was freeze dried and white fluffy 
product collected. Yield: 410mg - 89% 
 
Figure 3.12. NMR spectrum of poly(Lys40-st-Tyr10) in D2O. 
 
Synthesis of Urazoles  
Little et. al. reported high scale synthesis of urazoles starting from isocyanates, amines 
and carboxylic acid.
32
 We used isocyanates as precursors since it was the most 
practical (no column, simple washing to remove unreacted material). However, using 
amines makes more sense where purity of the isocyanate is questionable or the 
isocyanate is too reactive to handle such as PEG-isocyanate. 
 
Hexamethylene bisurazole  
Step 1 (Hexamethylene bishydrazine carboxylate): Ethyl carbazate (5,02 g; 48 
mmol) was dissolved in 30 mL of anhydrous THF under inert atmoshphere. Then a 
solution of hexamethylene diisocyanate (4,03 g; 24 mmol) in anhydrous THF (30 mL) 
was added to this solution dropwise at 0
o 
C. After 2-3 min. precipitation of the product 
was observed. The mixture was stirred for 2 hours and the collected product washed 
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with an excess THF. The final product was dried under vacuum to give a white 
material (8,7 g, 23 mmol, 96%). 
 
 
 
Figure 3.13. 
1
H-NMR spectrum of hexamethylene bishydrazine carboxylate in dmso-
d
6
. 
Step 2 (hexamethylne bisurazole 6): 5 grams(13,21mmol) of hexamethylene 
bishydrazine carboxylate was suspended in 150 mL absolute ethanol. 6.2g (45mmol) 
of anhydrous potassium carbonate was added to this solution and heated to reflux for 
one day. Then the ethanol was evaporated and the crude material dissolved in 
deionized water/ice. Afterwards concentrated HCl was added dropwise at 0
o
C until the 
pH of the solution became 1-2. Then the product was collected by filtration and 
washed with an excess of deionized water. Finally, the product was dried under 
vacuum (2,01 g, 7.08mmol, 53%) 
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Figure 3.14. 
1
H-NMR spectrum of hexamethylene bisurazole in dmso-d
6
. 
 
Methylene diphenyl bisurazole 5 
Step 1 (methylene diphenyl bishydrazine carboxylate): Ethyl carbazate (5,02 g; 48 
mmol) was dissolved in 30 mL of anhydrous THF under an inert atmoshphere. Then a 
solution of methylenediphenyl diisocyanate (6.06 g; 24 mmol) in anhydrous 30 mL 
THF was added dropwise to this solution at 0
o 
C. The reaction was stirred for one hour 
and all solvent evaporated under vacuum. Yield: 100 %.  
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Figure 3.15. NMR spectrum of Methylene diphenyl bishydrazine carboxylate in dmso-
d6. 
 
Step 2 (methylene diphenyl bisurazole 5): 5 g (10,83mmol) of methylene diphenyl 
bishydrazine carboxylate refluxed in 4N KOH (12 mL) solution overnight. After 
reaction cooled down and concentrated HCl is added dropwise at 0
o
C until pH of the 
solution becomes 1-2. Then, product was collected by filtration and washed with 
excess deionized water. Finally, product was dried under vacuum to give white 
powder. (Yield: 2.57g, 7.03mmol, 65%)  
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Figure 3.16. NMR spectrum of Methylene diphenyl bisurazole in dmso-d6. 
Ethyl 4-urazole benzoate 
Step 1 (ethyl 4-hydrazine carboxylate benzoate): Ethyl carbazate 2.08g (20mmol) 
was dissolved in 15 mL anhydrous THF under inert atmosphere. Then solution of ethyl 
4-isocyanatobenzoate 3.82g (20 mmol) in 15 mL anhydrous THF was added to this 
solution dropwise at 0
o 
C. The reaction was stirred for 1 hour and the product collected 
by filtration. Isolated yield: 5.42g, 92%       
65 
 
 
Figure 3.17. NMR spectrum of Ethyl 4-Hydrazine Carboxylate Benzoate. 
Step 2 (ethyl 4-urazole benzoate): 5g (17 mmol) of 4-Ethylbenzoate hydrazine 
carboxylate was suspended in 150 mL absolute ethanol. 3 g (21 mmol) of anhydrous 
potassium carbonate was added to this solution and heated to reflux for 16 hours. 
Then, ethanol was evaporated completely and the crude product dissolved in deionized 
water/ice mixture. Afterwards, concentrated HCl was added dropwise at 0
o
C until pH 
of the solution became 5-6. Then, the product was collected by filtration and washed 
with an excess of deionized water. Isolated yield: 3.34g, 79% 
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Figure 3.18. NMR spectrum of Ethyl 4-urazole benzoate. 
 
Urazole benzoic acid: 4-Ethyl urazole benzoate 2 g (8 mmol) was suspended in 20 
mL H2O. To this solution 2,2g (16 mmol) of KOH was added and stirred at 80
o
C for 
30 min. The solution was cool down to 0
o 
C and acidified to pH 1-2. The product was 
collected by filtration. Yield: Quantitative 
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Figure 3.19. NMR spectrum of ethyl 4-urazole benzoic acid in dmso-d
6
. 
 
Oxidation of Urazoles 
Oxidation of urazoles to corresponding TADs has been extensively studied since 1960 
when Cookson’s first isolation of TAD.33, 34 Especially by Mallakpour and Zolfigol.35-
43
  We have tried some of these conditions to oxidize our urazoles. Using commercially 
available 1,3-dibromo-5,5-dimethylhydantoin looked practical.
35
 However, we 
observed that oxidized product contains side product of oxidizing agent (dimethyl 
hydantion) and 2 or 4 mole equivalent of HBr (Figure 3.20). Therefore, we focused on 
the procedures with less side products. It is important because TADs are generally too 
reactive to purify. Using freshly prepared silica nitric acid as described in literature. 
The latter method gave slightly cleaner products free of side product of the oxidizer 
(methyl hyndantoin) but it still contains residual HNO3 which can be removed by 
rotavap. The drawback of silica nitric acid is the water coming from the aqeous nitric 
acid may decompose the TAD. However, using dichloromethane as a solvent and 
drying the oxidized solution over anhydrous MgSO4 before rotavap solves the 
problem.  
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Figure 3.20. Oxidation of Urazoles by commercially available DBDMH. 
 
In general, 100mg of urazole compound suspended in 6mL anhydrous acetonitrile or 
dichloromethane. 1.1 mole equivalent DBDMH dissolved 4mL of same solvent and 
added slowly in 1-2 minutes while string. The suspension turns into solution after 5-60 
min depending on the urazole. Then all the solvent evaporated by rotavap and pink or 
red compounds were collected. The yields will be misleading since product contains 
Methyl hydantoin side products 
.Figure 3.21. NMR spectrum of MDP urazole in DMSO-d6 (top) and MDP-bisTAD in 
acetonitrile-d3(bottom). 
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Figure 3.22. Stability of TAD derivatives in acetonitrile oxidized by DMBH. 
For silica nitric acid oxidation, we observed that using dichloromethane as solvent 
gives much cleaner product than acetonitrile. For oxidation, three times amount in 
grams of silica nitric acid  was added to urazole solution slowly in 5 minutes while 
stirring. The mixture was stirred for 2-3 hours and filtered. Then anhydrous MgSO4 
was added and stirred for 10 min. Finally, product was collected after filtering and 
evaporating all the solvents by rotavap. The isolated yields were generally 80-95%. 
 
Figure 3.23. NMR spectrum of Ethyl 4-TAD benzoic acid in dmso-d6.                
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Figure 3.24. NMR spectrum of hexamethylene bisTADs in acetonitrile-d3. 
                
Crosslinking of poly(Lys40-st-Tyr10) by HM-TAD 6: 30 mg of polypeptide was 
dissolved in a 0.2 mL acetonitrile/tris (1:1) mixture. To this solution 50 µL HM-
bisTAD stock solution was added (100 mg/mL, freshly prepared by silica nitric acid 
method) while stirring the solution. After 60-70 s the pink colour completely 
disappeared and gel formation was observed. The pale yellow gel was washed with 
THF to produce a clear gel.  
Conjugation of TAD derivatives: Unlike PTAD conjugation, TAD benzoic acid and 
Ethyl 4-benzoate TAD conjugations were not successful in 1:1 acetonitrile and tris 
buffer mixture. These compounds were immediately decomposed in these conditions. 
A brown precipitate formed and isolated polypeptide remained same with no 
conjugation. Therefore, we lowered aqeous part to slow down decomposition. 
COOH-PTAD conjugation: 30mg (approx. 7.2mg, 0.043mmol Tyr) of poly(Lys40-st-
Tyr10) was dissolved in 0.3mL DMF and 0.03mL DI water. To this solution 12mg 
(0.054 mmol) of COOH-PTAD in 0.15mL DMF is added dropwise. Red color of 
TAD-benzoic acid disappeared instantly. The solution stirred for 2 min more and 
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diluted with 3 mL DI water and placed into 3.5 MWCO dialysis bag. After 4 days, 
dialysis product was collected by freeze dryer and characterized by NMR (Figure 
3.25). Conjugation yield was calculated as 81% from NMR integration. 
Ethyl 4-benzoate TAD conjugation: The same procedure was followed. However, 
the resulting polymer was not soluble in water anymore. Additionally, side products 
were observed indicating that TAD was decomposed and reacted with lysine. 
 
Figure 3.25. NMR spectrum of COOH-PTAD attached poly(Lys40-st-Tyr10) in D2O. 
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Figure 3.26. NMR spectrum of Benzoate-PTAD attached poly(Lys40-ran-Tyr10) in 
dmso-d6. 
Glucosylation of poly(Lys40-ran-Tyr10)  followed by PTAD: 300 mg of poly(Lys40-
ran-Tyr10)  was dissolved in 3 mL DMSO and 0.3 mL water. To this solution 30mg 
(0.15mmol) of D-(+)-gluconic acid δ-lactone was added and stirred for 24 hours 
(Figure 3.27). Then the solution was placed into a 3.5 MWCO snake skin dialysis bag 
and dialyzed against DI water for 3 days. The polypeptide was obtained by freeze 
drying. Then, 50 mg of this polypeptide was dissolved in 1 mL of MeCN/0.1M tris 
buffer (1:1). To this solution 8 mg (0.04mmol) of PTAD (in 0.1 mL MeCN) was added 
together with 0.1 ml tris buffer. The red solution turned into orange and pale brown in 
3-4 min. After 30 min, the solution was put into 3.5 MWCO dialysis bag and dialysed 
for 3 days. Finally, the solution was freeze dried and characterized by NMR (Fig 3.28). 
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Figure 3.27. NMR spectrum of sugar functionalized poly(Lys40-ran-Tyr10) in dmso-d6. 
 
 
Figure 3.28. Orthogonal functionalization of partially glucosylated lysine. PTAD 
functionalization carried out in 1:1 MeCN/Tris buffer. 
1st –PTAD 
2nd - Glucosylation OK 
1st –PTAD 
2nd - Glucosylation OK 
1st –PTAD 
2nd - Glucosylation 
OK 
1st –PTAD 
2nd - Glucosylation 
OK 
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Figure 3.29. 
1
H-NMR of rrthogonal functionalization of fully glucosylated lysine in 
 dmso-d6.  
 
When polypeptides were fully glycosylated, it became insoluble in acetonitrile/tris 
buffer. PTAD functionalization was tested in DMF but it was unsuccessful (Figure 
3.29).  
3.4 Conclusion 
In conclusion, combination of NCA polymerization with tyrosine-TAD reaction has shown to 
be a very efficient method to prepare well defined functionalized polypeptides and polypeptide 
based hydrogels. Further functionalization of tyrosine can be done with novel TAD 
compounds such as PEG-TAD or glucose-TAD. However, the stability of these compounds in 
aqueous media will determine the functionalization efficiency. Interestingly, stable 
bifunctional TAD compounds will enable researchers to prepare novel polypeptide hydrogels 
where amino acids such as lysine, glutamic acid or cysteine remain unaffected or free for 
functionalization. 
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 Chapter 4  
 Tryptophan-TAD Functionalization 
Abstract 
In the previous chapter, it was demonstrated that the TAD-tyrosine functionalization is 
challenging due to the decomposition of TAD in aqueous conditions. Therefore, there 
is a limited synthetic window in terms of reaction parameters for the TAD-tyrosine 
reaction. On the other hand, tryptophan readily reacts with TAD in organic solvents 
such as chloroform, DMF, acetonitrile, and their mixtures where TADs are stable. In 
order to investigate tryptophan-TAD reaction, a library of tryptophan-containing 
copolypeptides was prepared. The copolypeptides were then functionalized with 
PTAD, TAD Benzoate, PEG-bisTAD and PEG-monoTAD (PEGylation). Finally, we 
explored secondary functionalization on those polypeptides with thiol-ene and copper 
catalyzed azide-alkyne cycloaddition.    
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4.1. Introduction 
An ideal functionalization reaction (such as a click reaction) should be selective, 
highly efficient, and ideally be free of impurities.
1
 For polymer modifications, there are 
also other requirements to fulfill, such as equimolar functionalization and complete 
removal of side products by an easy work up, e.g. precipitation (Figure 4.1). Click 
reactions such as azide-alkyne cycloaddition or Diels-Alder reactions generally meet 
these requirements.
2
 On the other hand, a copper-catalyzed azide-alkyne click reaction 
might not be suitable for polymer modifications targeting biological applications 
unless copper (I) is completely removed or converted into copper (II).
3
 Click-like thiol-
ene reactions seem more suitable in those cases as they are either catalyzed or 
triggered by light irradiation.
4
 Light irradiation has the advantage of not requiring 
additional chemical activators and as such finds applications in the biomaterials 
sector.
5
   
 
Figure 4.1. Proposed definition of small molecule click reactions and polymer specific 
click reactions.
2 
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Diels-Alder reactions do not necessarily require a catalyst but the adduct formation 
depends on the reaction temperature.
6
 Some dienes or dienophiles are so reactive that 
they readily react at -78
o
C whereas others may require higher temperatures and several 
hours to be completed. A Diels-Alder reaction that fulfills the requirements of high 
efficiency and fast reaction rate was introduced in 1962 by Cookson et al., who 
synthesized a very reactive dienophile known as 4-phenyl-TAD (PTAD).
7
 They 
showed that PTAD quantitatively reacts with cyclopentadiene at -78
o
C.
8
 Although 
PTAD is highly reactive towards dienes, it is reasonably easy to handle and storable as 
a powder.
9
 Additionally, TADs are also reactive towards vinyl ethers
10, styrene, or β-
diketones.
11
  In 1980, G. B. Butler mentioned the importance of TADs in his review 
paper by stating that “TADs are low-temperature modifiers with exceptional 
versatility”.11 In the past, TAD functionalization was studied for the modification as 
well as crosslinking of polymers in order to tune their mechanical properties. However, 
they did not receive much attention as an alternative click reaction. TAD became 
popular in biology for fluorescence labeling of vitamin D, vitamin A and some other 
biologically important molecules by DMEQ-TAD (Figure 4.2).
12,13,14
 In 2003 Corey et 
al. reported for the first time that indole can be protected and deprotected by TAD 
(Figure 4.3).
15
 They demonstrated that the TAD-indole reaction is catalyst and side 
product free as well as reversible at high temperature. Compared to other click 
reactions, TAD chemistry is much easier to carry out. Simple mixing of TAD with the 
indole-containing product in open air and room temperature is generally sufficient for 
completion of the reaction.  
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 Figure 4.2. DMEQ-TAD labeling of vitamin D.
12 
 
Figure 4.3. Protection-deprotection method of indole 2,3-π bond.15 
 
Recently, TAD chemistry was rejuvenated and now receives increasing attention 
highlighted in a number of examples. The Du Prez et. al. demonstrated that thermal 
reversibility and ultrafast kinetic of TAD-indole reaction can be exploited to create a 
dynamic polymeric system for potential self-healing, recyclable, reshapeable and 
rewritable materials (Figure 4.4).
16,17
 The same group also showed the practicability of 
TAD-diene reactions by preparing 58 layer organic films in 20 minutes.
18
 Zhang, Du 
Prez and their coworkers further demonstrated that polymer-polymer coupling can 
efficiently be done by TAD-diene chemistry.
19,20
 This additive free coupling process 
can be monitored by the disappearance of the distinct red color of the TAD upon 
reaction. Fabrication of highly elastic sustainable materials by crosslinking plant oils 
by TAD was reported by Wang et al.
21,22
 Firstly, they synthesized triblock oil based 
copolymer, namely poly(styrene-b-soybean oil acrylate-b-styrene), via ATRP 
polymerization. Then, these polymers were crosslinked from their middle block by 
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4,4′-(1,4-phenylene)-bis(1,2,4-triazoline-3,5-dione). The crosslinking helped to achieve 
excellent mechanical properties where oil based polymers generally fall short.    
 
Figure 4.4. At high temperature, TAD gives a retro reaction with indole while it binds 
to conjugated diene irreversibly.
16
 
TAD-furan reactions are less explored compare to the other TAD reaction. This 
reaction also constitutes a click reaction. To date, there are only two reports on TAD-
furan reactions. In 2007, the Gleason group showed deposition of PTAD onto furan 
containing film. The film was cast from commercially available furfuryl 
methacrylate.
23
 The second example was developed in the Madder group showing 
orthogonal peptide labeling by the PTAD-furan reaction (Figure 4.5).
24
 Furan 
containing peptide was prepared using commercially available synthetic amino acid 
furylalanine via SPPS.  
83 
 
 
Figure 4.5. Furan group reacts with TAD either in Diels-Alder reaction or 
electrophilic aromatic substition.
24 
The natural amino acid tryptophan contains an indole group which can be used for 
TAD functionalization. In this chapter, TAD-tryptophan functionalization was 
investigated for copolypeptides prepared by NCA polymerization. This strategy offers 
significant advantages over established (click) conjugation approaches on synthetic 
polypeptides. While thiol-ene
25–27
, thiol-yne
28–31
 as well as azide alkyne
32–36
 click 
reaction have been exploited for synthetic polypeptides, they are all based on non-
natural amino acids, which need to be specially synthesized.
37,38
 Even though 
conjugation approaches on natural amino acids have been reported such as thiol 
reaction on cysteine,
39,40
 TAD reactions on tyrosine and various chemistries on 
glutamic acid,
41–45
 aspartic acid
46
 as well as lysine,
47–49
 the incompatibility of their 
functional groups with the NCA ring demands the protection and polymer analogous 
deprotection of these amino acids prior to their conjugation. A successful tryptophan-
TAD reaction would overcome these additional steps.  
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4.2. Results and Discussion 
4.2.1 The TADs for Functionalization and Crosslinking 
The list of TADs used in this chapter is shown in Figure 4.6. Syntheses of HM-
bisTAD and ethyl 4-TAD benzoate were described in Chapter 3. PEG-bisTAD and 
PEG-monoTAD were synthesized from PEG-bisamine and PEG-monoamine in three 
steps as shown in figure 4.7. 
 
Figure 4.6: TAD derivatives for tryptophan functionalization. 
 
Figure 4.7: Synthesis of PEG-bisTAD 
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Synthesis of PEG-TAD 
In the first step, the PEG-bisamine was reacted with CDI and ethyl carbazate to form 
the PEG-hydrazinecarboxylate. The CDI impurities from this step could easily be 
removed by dialysis (Appendix Figure 1). For an efficient dialysis, all THF must be 
evaporated and the remaining solid dissolved in DI water. In the second step, PEG-
hydrazinecarboxylate was converted to PEG-urazole under basic conditions (K2CO3, 
ethanol) and the product was purified by dialysis. In this step, all the ethanol must be 
evaporated and the solid be dissolved in DI water, while the pH should be set to 7 to 
prevent damage to the dialysis tubing from acid or base. Unless sufficient time was 
given for urazole formation, a mixture of PEG-hydrazinecarboxylate and PEG-urazole 
might be obtained (Appendix Figure 2). After dialysis, the product was recovered by 
freeze drying, which helped to obtain an extremely dry PEG-urazole. PEG-
hydrazinecarboxylate and PEG-urazole formation were confirmed by 
1
H-NMR (Figure 
4.8 and Figure 4.9).  
 
Figure 4.8: 
1
H-NMR spectrum of PEG-bishydrazinecarboxylate in dmso-d6. 
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Figure 4.9: 
1
H-NMR spectrum of PEG-bisurazole in dmso-d6. 
The oxidation of PEG-urazole was done with silica nitric acid. It was observed that the 
oxidation in DMF, THF or acetonitrile was very slow (very faint pink solution – 
almost transparent). Additionally, the low-intensity color disappeared within 1-2 hours 
indicating PEG-TAD decomposition. On the other hand, oxidation in chloroform and 
dichloromethane resulted in a dark pink solution and the color was preserved for at 
least 24 hours at room temperature. The success of the oxidation step is evident from 
IR and NMR spectra. The infrared spectra (Figure 4.10) show that the peaks at 
carbonyl region at 1698 cm
-1
 disappeared and new peaks were observed between 1707 
and 1785 cm
-1
. Additionally, a new peak at 1394 cm
-1
 appeared, probably due to a 
change in C-N stretching (or N=N). From the 
1
H-NMR spectrum (Figure 4.11), it was 
calculated from the integration of NH peak at 10 ppm, that 95% of the urazole groups 
were converted into TAD within 15 minutes (15% w/w silica nitric acid). Full 
conversion as evident from the disappearance of the NH peak at 10 ppm, can be 
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achieved by increasing reaction time or silica nitric acid amount. The PEG-monoTAD 
was obtained following the same procedure starting from PEG-amine. 
 
Figure 4.10: IR spectrum of PEG-bisurazole (blue-neat) and PEG-bisTAD (red-neat).  
 
Figure 4.11: 
1
H-NMR spectrum of PEG2K- bisTAD in dmso-d6. The peak at 10 ppm 
represents the H-N of non-oxidized urazole. 
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4.2.2 Synthesis of the Monomer: Tryptophan NCA 
Tryptophan NCA was reported in the literature by direct phosgenation of L-tryptophan 
with triphosgene (Figure 4.12).
50–52
 We optimized the reported procedure by adding 
triphosgene dropwise over a longer period (instead of adding at once as reported) and 
crystallizing the obtained NCA with heptane/ethyl acetate mixture (instead of only 
ethyl acetate). Evidence of ring formation can be obtained from the 
1
H-NMR spectrum 
(Figure 4.13), specifically from characteristic protons 5 and 6. This is supported by 
13
C-NMR (Figure 4.14) displaying NCA specific signals from carbons 2, 11 and 12. 
The IR spectrum (Figure 4.15) shows the typical NCA carbonyls 1842 cm
-1
 and 1773 
cm
-1
. Those peaks also disappear after polymerization allowing easy monitoring of the 
reaction progress.   
 
Figure 4.12: Synthesis of tryptophan NCA 
Upscaling of the tryptophan NCA synthesis (>10 g) enabled the preparation of large 
amounts of tryptophan containing polypeptides, which were used for the synthesis of 
hydrogels by the tryptophan-TAD reaction for biocompatibility studies and mechanical 
analyses (Chapter 5).  
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Figure 4.13:
1
H-NMR of tryptophan NCA in dmso-d6.  
 
Figure 4.14: 
13
C-NMR of tryptophan NCA in dmso-d6. 
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Figure 4.15: IR spectrum of tryptophan NCA (neat). The NCA carbonyl peaks are 
seen at 1842 cm
-1
 and 1773 cm
-1
. 
4.2.3 TAD-Tryptophan Functionalization and Crosslinking 
4.2.3.1 Reaction with PEG-Trp block copolymers 
We observed that the PEG-TAD derivatives were stable in chloroform and 
dichloromethane but not in DMF. Polypeptides are generally soluble in DMF, 
sometimes in chloroform and mixtures of these solvents or with other solvents such as 
acetonitrile.  Therefore, to test the PEG-TAD reaction with polypeptides, we aimed to 
prepare a tryptophan polypeptide initiated from PEG2K-amine as PEG would facilitate 
the polypeptide solubility. The success of this reaction is evident from the 
1
H-NMR 
spectrum yielding a tryptophan block length of 5-6 units (Figure 4.16). This polymer 
was soluble in dichloromethane and when mixed with PEG-bisTAD (Trp:TAD 1:1), a 
hydrogel was obtained within 5-10 seconds (Figure 4.18 and 4.19). When the reaction 
was carried out in chloroform an instantaneous reaction was observed, in some cases 
leading to inhomogeneous gels. 
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Figure 4.16. 
1
H-NMR spectrum of PEG2K-amine and PEG2K-tryptophan in dmso-d6. 
 
Figure 4.17.  Hybrid polypeptide hydrogel made by tryptophan-TAD click.  
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Figure 4.18.  Crosslinking PEG-Trp polypeptide with PEG-bisTAD in 
dichloromethane. The reaction was fast and the color disappears within 5-10 s if 
shaken vigorously. 
  
Figure 4.19.  Crosslinking poly(z-Lys-st-Trp) with PEG-bisTAD in chloroform. 
Instantaneous reaction prevents proper mixing and resulted in a precipitate like 
gelation. 
4.2.3.2 Reaction with Poly(Z-Lys-st-Trp) Copolypeptides 
For further tests of TAD functionalization, a statistical copolymer of tryptophan and Z-
lysine (denoted P6) was prepared by hexyl amine initiator with tryptophan NCA to Z-
lysine NCA ratio of 15:85 (Figure 4.20). Quantitative copolymerization was monitored 
with the help of FTIR spectroscopy by the disappearance of the NCA carbonyl peaks 
at 1842 cm
-1
 and 1773 cm
-1
 (Figure 4.15) and appearance of polypeptide backbone 
amide peaks at 1696 cm
-1
 and 1648 cm
-1
 (Figure 4.21). 
1
H-NMR analysis (Figure 4.22) 
of the copolymer largely confirmed agreement of the polymer composition, poly(Z-
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Lys85-st-Trp15), with the monomer feed ratio, although overlapping peaks result in a 
somewhat reduced accuracy of the peak integration.  
 
Figure 4.20: Synthesis of poly(Z-Lys-st-Trp) 
 
 
Figure 4.21: FTIR spectrum of poly(Z-Lys-st-Trp). Characteristic polypeptide amide 
peaks can be seen at 1696 cm
-1
 and 1648 cm
-1
. 
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Figure 4.22: 
1
H-NMR of poly(Z-Lys85-st-Trp15) in DMSO-d6. 
TAD-tryptophan reaction may take place at C2 or C3 of indole group as shown in 
figure 4.23. However, the main product is more likely C2 adduct due to enhanced 
carbocation stability and less steric hindrance at intermediate step. In the following 
only the C2 adduct is presented since spectroscopically no conclusive evidence for the 
C3 adduct was found.  
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Figure 4.23. PTAD-Tryptophan reaction mechanism. 
Initially, poly(Z-Lys85-st-Trp15) was reacted with PTAD at a ratio of PTAD to Trp of 
1.1:1 in acetonitrile/chlorofom (1:1) mixture. 
1
H-NMR confirmed the success of the 
reaction from the presence of NH protons a and b in Figure 4.24.  
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Figure 4.24: 
1
H-NMR spectrum of poly(Z-lys85-st-trp-PTAD15). 
The IR spectrum of the reaction product shows that the additional carbonyl groups of 
the TAD moiety change the pattern in the carbonyl region after functionalization. 
Additional peaks at 1773 cm
-1
 and 1770 cm
-1
 were assigned to the carbonyls of PTAD 
(Figure 4.25). As a second TAD derivative, TAD-benzoate was investigated in this 
reaction and it was found that it reacts with tryptophan similar to PTAD. Simple 
mixing of the copolypeptide with the TAD solution at room temperature is sufficient 
and the reaction can be monitored by the color change. Although N-H protons of the 
copolypeptide backbone and the attached TADs were not identifiable in the 
1
H-NMR 
spectrum of TAD-benzoate product, the protons of the ethyl ester groups of TAD-
benzoate were clearly distinguishable (Figure 4.26).   
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Figure 4.25: IR spectrum of PTAD functionalized poly(Z-Lys90-st-Trp10). The 
carbonyl peaks pattern changed due to extra carbonyl peaks from PTAD. 
 
Figure 4.26: 
1
H-NMR of TAD-benzoate functionalized poly(Z-Lys85-st-Trp15) in 
dmso-d6. 
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GPC chromatograms show that the hydrodynamic volume has clearly shifted after 
copolypeptide functionalization. P6 (Mw: 9.66 kg/mol, PDI: 1.11) had the lowest 
elution time in DMF, while both P6-PTAD (Mw: 15.54 kg/mol, PDI: 1.18) and P6-
TADbenzoate (Mw: 15.89 kg/mol, PDI:1.28) eluted at a lower retention time (Figure 
4.27).  
 
Figure 4.27. GPC chromatogram of P6 (blue), P6 PTAD (red) and TAD-Benzoate 
functionalized P6 (green). 
The instantaneous reaction of P6 with PEG-monoTAD (1:1.1 eq. Trp: PEG-
monoTAD) was carried out in chloroform and the obtained copolymer analyzed by 
GPC. Comparison of the chromatograms before and after PEGylation highlights a 
clear shift to higher molecular weights evident of a successful PEGylation of the 
polypeptide (Figure 4.28). As an excess of PEG-TAD was used, a signal representing 
unreacted PEG-TAD can also be seen in the chromatogram.  
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Figure 4.28. SEC analysis of P6 before and after reaction with PEG-TAD. 
The TAD functionalizations with tryptophan are highly valuable because tryptophan 
NCA does not require protection-deprotection chemistry like other amino acids. 
Additionally, tryptophan is a natural amino acid that can be commercially obtained at a 
very affordable price and at high quality. The reaction is highly selective (because 
other amino acids are on protected form) so that other amino acids such as lysine, 
glutamic acid or cysteine can be used with tryptophan without concerns about their 
protecting groups or orthogonal deprotection strategies. Therefore, tryptophan-TAD 
functionalization is probably the easiest and most convenient modification method for 
the NCA-derived polypeptides to date.  
4.2.4 Co-Click Functionalization of Poly(Z-lys-st-trp) 
In this part, we explored how well TAD-tryptophan functionalization integrates with 
other common click reactions, i.e. thiol-ene and azide-alkyne cycloaddition. A similar 
copolypeptide of CBZ-lysine and tryptophan was synthesized using propargylamine 
and allylamine as initiators (poly(Lysine50-st-Trp20). This adds alkene and alkyne end 
groups to polypeptides (Figure 4.29).    
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Figure 4.29 NCA polymerization initiated by propargyl amine or allylamine 
4.2.4.1 Thiol-ene Functionalization Following PTAD 
PTAD functionalization of both copolymers was successfully done using the 
functionalization conditions described above. 
1
H-NMR spectra show that the alkene 
endgroups of the copolypeptides were still intact. The presence of alkene group can be 
seen at 5.70 ppm after polymerization (proton –i- in figure 4.31) and after PTAD 
functionalization (proton –i- in figure 4.32). 
 
Figure 4.30 Thiolene click reactions following TAD click on poly(Lys50-st-Trp20). 
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Figure 4.31: 
1
H-NMR of allylamine initiated poly(Z-Lys50-st-Trp20) in dmso-d6. 
 
Figure 4.32: 
1
H-NMR of PTAD functionalized poly(Z-Lys50-st-Trp20) in dmso-d6. 
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Thiol-ene reaction was then tested with the allylamine terminated poly(Z-Lysine50-st-
Trp20TAD) (Figure 4.30). PEGylation of the end group was attempted with PEG6K-
monothiol under UV irradiation and in the presence of a photoinitiator. The reaction 
product was washed extensively to remove all unreacted PEG. The NMR spectrum of 
the polymer clearly shows the presence of PEG suggesting a successful reaction 
although the reaction yield cannot be quantified by this method (figure 4.33).  
 
Figure 4.33: 
1
H-NMR of PEGylated - PTAD functionalized poly(Z-Lys50-st-Trp20) in 
 dmso-d6. New PEG peaks can be seen at 3.51 ppm. 
Further evidence for a successful reaction was obtained from SEC analysis. SEC 
chromatograms confirmed an increase on molecular weight upon PTAD reaction and 
PEGylation (Figure 4.34). The tailing of the final polymer trace suggests that the end-
group reaction with PEG-thiol was not quantitative, a conclusion that is not 
unreasonable considering the steric aspects of this polymer-polymer reaction. We 
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believe that the small peaks at ca. 22 min.  are due to the polyallylamine formation in 
allylamine bottle.  
While these preliminary results demonstrate the compatibility of the thiol-ene and 
TAD-Trp reactions, further optimization would be required to gain a better 
understanding of reaction conditions and selectivity. 
 
Figure 4.34. GPC chromatogram of allylamine initiated polypeptide (AP, green), its 
PTAD functionalization (AP-PTAD, red) and PEGylated polypeptide after PTAD 
attachment (AP-PEG, blue). 
4.2.4.2 Azide-Alkyne Functionalization Following PTAD 
As a second polymer, propargyl amine initiated copolypeptide was synthesized (Figure 
4.35).  While according to the polymerization mechanism the copolypeptide must be 
end-capped with the propargyl group, this is difficult to prove spectroscopically due to 
the low signal intensity of the propargyl group. The example of the 
1
H-NMR spectrum 
is presented in Figure 4.36. The polymer was then reacted with PTAD and the Lys 
deprotected , which made the copolymer water soluble.  
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Figure 4.35: Cu-catalyzed cycloaddition followed by PTAD functionalization and 
deprotection of the Cbz group. 
 
Figure 4.36: 
1
H-NMR spectrum of propargyl amine initiated poly(Z-Lys50-st-Trp20). 
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Finally, the propargyl end-group was reacted with an azide functional PEG in a 
azide/alkyne click reaction. FTIR spectrum of the product showed characteristic PEG-
azide (2107 cm
-1
) signal due to the use of an excess of this reactant.  After precipitating 
in ethanol, the PEG-azide peak has completely disappeared (Figure 4.37) highlighting 
the efficient removal of the unreacted PEG-azide. NMR data of the purified product 
display characteristic PEG peaks, which can only be explained from a successful 
reaction of the PEG-azide with the polymer end-group (Figure 4.38).   
 
Figure 4.37. IR spectrum of the crude of PEGylated PTAD-polypeptide and purified 
one. 
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Figure 4.38: 
1
H-NMR spectra of PTAD functionalized propargylamine initiated 
(Lys50-st-Trp20) i.e. deprotected polypeptide (red) and PEGylated polypeptide (green). 
 
4.3. Conclusion 
In conclusion, tryptophan-containing polypeptides with narrow PDIs were prepared by 
tryptophan NCA and lysine NCA. Successful reaction with TAD derivatives was 
demonstrated including the reaction with PEG mono and bis-TAD. Preliminary results 
suggest the compatibility of this reaction with thiol-ene and alkyne-azide click 
reactions.  This TAD-Trp reaction has high potential to be used frequently to modify 
NCA derived materials due to it is versatile and easy chemistry. Additionally, Trp is a 
natural amino acid and does not require protection-deprotection chemistry to be 
compatible with NCA polymerisation, unlike other natural amino acids.  
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4.4. Experimental 
Synthesis of Tryptophan NCA: Tryptophan (10g, 48,97 mmol) was placed into 250 
mL three neck round bottom flask and dried in vacuum oven for 2 days at 40
o
C. Then, 
100 mL of anhydrous THF added together with α-pinene (19.8 g, 17mL, 145mmol) 
under an inert atmosphere. The reflux condenser was placed and temperature set to 
50
o
C. Triphosgene (7g, 23.6 mmol) dissolved in anhydrous THF and added to this 
mixture dropwise using dropping funnel. The reaction mixture became clear yellow 
solution after 2-3 hours. Then, half of the solvent was evaporated using rotavap and 
solution precipitated into cold heptane and kept in -20
o
C overnight. Semi crystalline-
powder precipitate collected by vacuum filtration and recrystallized using 1:1 ethyl 
acetate/heptane mixture without stopping the stirring while cooling period of 
crystallization. Yellowish white powder collected by vacuum filtration and dried in the 
vacuum line. Yield: 7.47 g, 66.2%. 
1
H-NMR (400 MHz, DMSO, ppm): 3.13-3.19 (dd, 
2H), 4.76 (t, 1H), 6.98 (m, 1H), 7.07 (m, 1H), 7.13 (d, 1H), 7.35 (d, 1H), 7.52 (d, 1H), 
9.05 (s, 1H), 10.57 (s, 1H). 
13
C-NMR (400 MHz, DMSO-d6): 26.42, 58.18, 106.98, 
111.39, 118.39, 118.57, 121.05, 124.44, 127.15, 135.93, 151.83, 171.23. FTIR(neat, 
cm
-1
): 3355, 3002, 1842, 1773, 1618, 1491, 1457, 1432, 1432, 1359, 1337, 1289, 1232, 
1177, 1133, 1104, 1081, 1007, 977, 933, 899, 814, 783, 764, 750, 674, 650, 633, 609.  
Synthesis of Poly(Lys85-Trp15): 2600 mg of Lysine NCA (8.5 mmol) and 345 mg of 
Trp NCA (1.5 mmol) was added into dried schelenck line under inert atmosphere and 
dissolved in 15 mL DMF. To this solution, 10.7 mg of benzylamine (0.1 mmol) from 
stock solution was added fast and the solution stirred under vacuum. After, 5-6 hours 
the solution was precipitated into diethyl ether. The sticky product was dissolved in 
chloroform and reprecipitated into diethyl ether. Finally, non-sticky powder product 
was collected by vacuum filtration and dried under vacuum. Yield: 2.23g, 91 %   
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Synthesis of P6–PTAD: 200mg of poly(lys90-st-trp10) dissolved in 2 mL 
chloroform/acetonitrile (1:1). Commercially available PTAD (12 mg – theoretically 1 
eq. to tryptophan) was dissolved in 0.2 mL acetonitrile and added to the polymer 
solution. The red color of PTAD was disappeared after 40-60 minutes indicating no 
more PTAD left in the solution. Then, the solution was precipitated into diethyl ether 
and collected by vacuum filtration. Isolated yield: 205 mg 
Synthesis of P6-TAD Benzoate: 200mg of poly(lys90-st-trp10) dissolved in 2 mL 
chloroform/acetonitrile (1:1). TAD-Benzoate (17.2 mg, 1eq. to tryptophan, synthesis in 
chapter 3) was dissolved in 0.2 mL acetonitrile and added to the polymer solution. The 
red solution became colorless after 10-20 minutes indicating no more TAD left. Then, 
the solution was precipitated into diethyl ether and collected by vacuum filtration. 
Isolated yield: 204 mg.  
Synthesis of PEG2K- bishydrazine carboxylate:  44 mg Ethyl carbazate dissolved in 
2 mL anhydrous THF. To this solution, 65 mg of CDI added in portions over 15 min. 
Then, 400mg of PEG2K-diamine (dissolved in 2mL) added to the first solution and 
stirred 24 hours. After, all THF was evaporated by rotavap. The resulting solid 
dissolved in DI water, filtered and placed into a dialysis bag (0.1-0.5 kDa). The 
solution was dialyzed for 2 days and product collected as a white powder after freeze-
drying. Isolated yield: 381mg 
Synthesis of PEG2K-Bisurazole: PEG2K- bis hydrazinecarboxylate (250mg, approx. 
0.24 mmol of hydrazine carboxylate end) was dissolved in 5mL of absolute ethanol. 
To this solution, anhydrous potassium carbonate (66 mg, 0.48 mmol) was added and 
the mixture was refluxed for 24 hours. Then, all ethanol was evaporated and remaining 
solid was dissolved in deionized water. The solution was neutralized by HCl carefully 
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and placed into a dialysis bag. Finally, it was dialyzed against DI water for 2 days and 
the white product was obtained by freeze drying. Isolated yield: 195mg 
Synthesis of PEG2K-TAD: 100mg of PEG2K-Urazole was dissolved in 1 mL of 
anhydrous chloroform. To this solution, 15 mg of silica nitric acid was added and 
shake for 15 minutes. Then the solution was filtered and precipitated into diethyl ether. 
The product was collected as a pink powder. Isolated yield: 79mg, conversion of 
urazole ends to TADs: 95% from NMR. Giving more time or using higher amount 
silica would help for full conversion. 
PEGylation of P6: 60 mg of P6 was dissolved in chloroform. To this solution, 50 mg 
of PEG2K-monoTAD was added and stirred for 10 minutes. Then, the solution was 
precipitated into diethyl ether. The resulting product was characterized by GPC.  
Synthesis of Allyl-Poly(Lysine50-Trp20): 1 g of lysine NCA (3.3 mmol) and 300mg of 
Tryptophan NCA (1.32 mmol) was placed into an oven dried schelenk tube and 
dissolved in 10 mL DMF. To this solution, 3.7 mg of allyl amine (0.5 mL from freshly 
prepared stock) was added and the reaction stirred for 6 hours. Then, the solution was 
precipitated into diethyl ether. The resulting sticky product was dissolved in 
chloroform and reprecipitated into diethyl ether to obtain non-sticky powder product.  
Synthesis of Allyl-Poly(Z-Lysine50-st-Trp20)–PTAD: 200 mg of Allyl-
Poly(Lysine50-Trp20) was dissolved in 2mL DMF/CHCl3 (1:1). To this solution, 60 
mg of PTAD was added and the reaction was stirred for 30 minutes. Then, the solution 
was precipitated into diethyl ether and the product was collected by vacuum filtration. 
Isolated yield: 216 mg 
Synthesis of Allyl Poly(Z-Lysine50-Trp20) – PTAD – PEG: 150 mg of Allyl-
Poly(Lysine50-Trp20) – PTAD was dissolved in 5 mL of CHCl3. To this solution, 48 
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mg of PEG-6K Thiol was added together with 2 mg of 2,2-Dimethoxy-2-
phenylacetophenone. Then, the reaction solution was irradiated with UV light for 2 
hours. Finally, the solution was precipitated into diethyl ether and collected by vacuum 
filtration. Isolated yield: 162 mg. 
Synthesis of Propargyl-Poly(Z-Lysine50-Trp20): 1 g of lysine NCA (3.3 mmol) and 
300mg of Tryptophan NCA (1.32 mmol) was placed into an oven dried schelenk tube 
and dissolved in 10 mL DMF. To this solution, 3.6 mg of allyl amine (0.5 mL from 
freshly prepared stock) was added and the reaction stirred for 6 hours. Then, the 
solution was precipitated into diethyl ether. The resulting sticky product was dissolved 
in chloroform and reprecipitated into diethyl ether to obtain non-sticky powder 
product.  
Synthesis of Propargyl-Poly(Z-Lysine50-st-Trp20)-PTAD: 200 mg of Allyl-
Poly(Lysine50-Trp20) was dissolved in 2mL DMF/CHCl3 (1:1). To this solution, 60 
mg of PTAD was added and the reaction was stirred for 30 minutes. Then, the solution 
was precipitated into diethyl ether and the product was collected by vacuum filtration. 
Isolated yield: 221mg 
Synthesis of Propargyl-Poly(Lysine50-st-Trp20)-PTAD: 200 mg of Propargyl-
Poly(Z-Lysine50-Trp20) was dissolved in 5 mL of TFA. To this solution, 0.3 mL of 
HBr (33% in acetic acid) was added and stirred for 5 hours. Then, the solution was 
precipitated into diethyl ether, washed with excess diethyl ether and dried. The solid 
was dissolved in deionized water and placed into 3.5 MWCO snake skin dialysis bag. 
The product was collected by freeze drying after 2-3 days of dialysis. Isolated yield: 
134 mg. 
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Synthesis of Propargyl-Poly(Z-Lysine50-Trp20)-PTAD-PEG: 60 mg of Propargyl-
Poly(Lysine50-Trp20)-PTAD was dissolved in 1 mL of DI water. To this solution, 10 
mg of PEG1K-azide was added together with 5 mg CuSO4.5H2O and 3.5 mg of 
sodium ascorbate. The reaction was stirred overnight. Then, the mixture was filtered 
and the crude product was obtained after evaporation of the water by rotavap. Then, 
the product was redissolved in a minimum amount of water and precipitated in ethanol. 
Finally, the product was collected by vacuum filtration and dried on the vacuum line. 
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4.6 Appendix 
 
Figure A1: 
1
H-NMR spectra of PEG2K- bishydrazine carboxylate in dmso-d6. 
Dialysis and optimized conditions helped to get rid of CDI impurity. 
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Figure A2: 
1
H-NMR spectra of PEG2K- bisurazole in dmso-d6. For full conversion at 
least 24 hours of reflux was needed. 
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 Chapter 5 
 Tryptophan Based Hydrogels 
Abstract 
In the previous chapter, it was demonstrated that the TAD-tryptophan reaction is very 
versatile. This chapter investigates how well-defined polypeptide based hydrogels can 
be prepared utilizing this reaction. First, a library of co-polypeptides with varying 
tryptophan content was prepared; then, these copolypeptides were crosslinked using 
hexamethylene-bisTAD to obtain organogels. Finally, these organogels were converted 
into hydrogels by removing the hydrophobic protection groups on the amino acids. 
The gelation kinetics were controlled by either the concentration of crosslinker or 
tryptophan concentration in the polypeptide. Additionally, it was observed that solvent 
composition can also be used to control the speed of gelation. Hydrogel 
microstructures were imaged using SEM and mechanical analyses were completed. 
Cytotoxicity studies revealed that the hydrogels were not toxic to human mesenchymal 
cells. TAD-tryptophan crosslinked materials have high potential for use as biomaterials 
since the composition of amino acids and mechanical properties of these gels can be 
very easily tuned by this chemistry.  In the last part of this chapter, a new type of 
organohydrogel is reported. This new class of material was obtained by diffusion 
controlled deprotection of the hydrophobic groups resulting in a macroscopic core-
shell type symmetrical hybrid material where the core is hydrophobic and the shell is 
hydrophilic.    
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5.1. Introduction 
5.1.1 Polypeptide Based Hydrogels 
Hydrogels have been used in many applications particularly in biology related fields 
since their first introduction in 1960 by Wichterle and Lim.
1
 In the 1980s, 
encapsulation of cells by calcium alginate gels
2
 and the use of natural polymer 
hydrogels as burn dressings
3
 showed the high potential of hydrogels in real medical 
applications. Today, numerous types of hydrogels are used or explored in many areas, 
including pharmaceuticals
4
, tissue engineering
5–8
, regenerative medicine
9–11
, wound 
dressing
12
 and biosensors
13,14
. The high water content of hydrogels allows the 
movement of small molecules, a critical feature for many bio-applications apart from 
biodegradability and biocompatibility.
15
 Some hydrophilic polymers like PEG (FDA 
approved) are widely used as crosslinkers to obtain hydrogels
16,17
, however, the 
resulting materials are not biodegradable. Additionally, while PEG itself may be 
biocompatible, its derivatives such as PEG-acrylate or PEG-isocyanate still contain 
non-biocompatible functionalities. Moreover, higher molecular weight PEGs are not 
excreted from the body and accumulate in the liver which may cause health 
problems.
18
   
Natural polymers such as collagen or chitosan may be more suitable for in vivo 
applications than high molecular PEGs because of their biodegradability. Although 
natural polymers have  some advantages such as cell binding sites, they may cause 
alterations to cell properties.
19
 Lack of accessible functional groups, compositional 
varieties depending on source, non-scalable production, and possible immune 
responses
20
 are among the disadvantages of natural polymers for systematic 
biomedical applications. Polymers consisting of natural building blocks that grant 
control over composition and functionalization are interesting alternatives. Aliphatic 
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polyesters, polypeptides, polyphosphoesters, polyanhydrides and polyurethanes 
generally meet these criteria, but further modification chemistries should be taken into 
account.
21
  
There are many reports on hydrogels made of NCA derived polypeptide materials.
22,23
 
Most of these reports are based on stimuli-responsive
23–25
 sol-gel behavior or self-
assembly of 
26–28
 diblock amphiphilic copolypeptide. Not only copolypeptides but also 
copolymer hybrids were reported to form hydrogels. For example, Cho. et al. reported 
a biodegradable hydrogel composed of hexablock hybrids of PEG and PBLG, where α-
helical assembly results in supramolecular crosslinking.
29
 The role of the PEG is to 
provide a hydrophilic block, whereas PBLG block is hydrophobic. Due to the 
amphiphilic diblock character the polymers self-assembled to form supramolecularly 
crosslinked gel. Another PEG-polypeptide hybrid namely poly(ethylene glycol-b-(γ-
(2-methoxyethoxy)ester-L-glutamate), was also reported to form hydrogels.
30
 In both 
reports, polypeptide blocks not only provide hydrophobicity but also biodegradability. 
Biodegradation of the polypeptide blocks breaks the gel network and can thus be used 
to deliver drugs or biologics. Huang et al. reported thermoresponsive gelation of PEG-
Tyr block hybrid polymers, where β-sheet formation of the tyrosine block at higher 
temperatures induces gelation.
31
 This is one of few examples showing gelation upon 
increasing temperature. One drawback of supramolecular hydrogels is their mechanical 
properties. They are generally too weak to handle and use in real life applications 
where a strong and stable material is needed. On the other hand, the stimuli-responsive 
sol-gel behavior of these gels makes them interesting materials for certain applications 
such as injectable hydrogel systems.
32
   
In this chapter, the natural amino acid tryptophan was crosslinked using the TAD click 
reaction to obtain gels. The details of the reaction were discussed in Chapter 4. To date 
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there are only two reports on tryptophan bioconjugation.
33–36
 The first bioconjugation 
of tryptophan was reported 2006 by Antos et al. (Figure 5.1).  A vinyl diazo compound 
(1) was catalyzed with rhodium (II) acetate to obtain rhodium carbenoids (2) and 
tryptophan was conjugated through this intermediate. However, it should be noted that 
the rhodium carbenoids also reacts with water. Additionally, this reaction only works 
under very acidic conditions (pH 2).  
 
Figure 5.1. Bioconjugation of tryptophan by rhodium carbenoids.
33
 
The second method used to conjugate tryptophan was reported in 2016 by Seki et al.
36
 
While investigating serine selective cleavage of a polypeptide by 9-
azabicyclo[3,3,1]nonan-3-one-9-oxyl (known as keto-ABNO)
37
, they noticed that 
peptides containing tryptophan formed an adduct. Then, by optimizing the reaction 
conditions they achieve transition metal free conjugation of tryptophan under mild 
conditions. (Figure 5.2) 
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Figure 5.2. Bioconjugation of tryptophan by azabicyclo[3,3,1]nonan-3-one-9-oxyl.
36
 
The rare and difficult chemistry on tryptophan suggests that TAD-tryptophan click 
reaction might be very valuable. However, this reaction is not ideal for tryptophan 
bioconjugation on natural proteins for two reasons. The gradual decomposition of 
TAD in an aqueous environment is an impediment for bioconjugation and, as critical, 
TAD mainly reacts with tyrosine rather than tryptophan (Chapter 3). While the TAD-
tryptophan click reaction may not be suitable for protein modification, it is the easiest 
method to modify NCA derived polypeptides. Firstly, tryptophan NCA does not 
require protection-deprotection chemistry, which reduces the whole synthesis by two 
steps. Secondly, it offers freedom for the selection of protection groups of co-amino 
acid monomers, since no orthogonality is needed. Secondly, TAD is stable in solvents 
in which protected polypeptides are soluble (CHCl3, DMF, acetonitrile). Therefore, 
polypeptides can be functionalized at their tryptophan residues immediately after NCA 
polymerization. Thirdly, tryptophan is a natural amino acid and there is no need for a 
tedious synthesis to obtain clickable NCA monomers, such as propargyl
38,39
 or allyl
40,41
 
glycine. Another natural amino acid that can be functionalized by different click 
reaction is thiol containing cysteine. However, cysteine cannot be used as NCA 
without prior protection of the thiol group.
42,43
 Additionally, formation of disulfide 
bonds might be challenging to work with.  
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5.1.2 Organohydrogel (Amphiphilic gel) 
During hydrogel synthesis, we observed a new type of macroscopic core-shell 
hydrophobic hydrophilic gel (an amphiphilic gel or organohydrogel). Diffusion 
controlled deprotection of hydrophobic groups resulted in this new type of 
organohydrogel. To the best of our knowledge, there have not been any reports on this 
type of gel or fabrication method (explained further in the Discussion section). 
However, there are reports on hydrogel-organogel hybrids, where two gels are 
basically glued to each other
44–46
 or two different monomers of high viscosities are 
polymerized and gelated.
47,48
  
In the first approach, adhesion of two type of gels presents difficulties regarding how 
well the interfaces are connected. Therefore, Biswas et al. modeled stacking of two 
different gels by two different methods. i.e. atom transfer radical polymerization 
(ATRP) and free radical polymerization (FRP) (Figure 5.3). They found that ATRP 
gels are weakly connected due to a lack of active radicals.
49
 The same group also 
reported that miktroarm star copolymers enhanced connectivity between the gels.
46
  
  
Figure 5.3. Modeling connections between gels shows that free radical polymerization 
provides better connectivity, compared to ATRP.
49 
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Deng et al. prepared a hybrid gel by adhering two PEG gels (Figure 5.4).
44
 Reversible 
acylhydrazone reaction was used to bond the PEG hydrogel (synthesized in water) to 
the PEG organogel (synthesized in anisole).    
 
Figure 5.4. Fabrication of macroscopic organohydrogel by rapid adhesion of PEG 
based organogel and PEG based hydrogel.
44 
Similar to Deng’s approach, Yong et al. reported a hybrid gel made by initiation of 
polymerization at the surface of the first gel (Figure 5.5). This work also had similar 
drawbacks, in particular, questionable interfacial connectivity. 
 
Figure 5.5. Macroscopic organohydrogel by grafting a on a second gel from a first 
gel.
16 
In the second approach, two monomers or polymers in sufficiently high viscosities are 
crosslinked, assuming that no diffusion occurs between the different monomer or  
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polymer regions. However, it is somewhat uncertain whether one distinct region 
remains “pure” and does not contain monomers or polymers of other region due to 
diffusion. Crosslinking high viscosity solutions is more suitable for light or heat 
induced reactions because crosslinking reagents have a longer diffusion time through 
medium (which is also the rational for the non-mixing for two monomers or polymers). 
Following this approach, Banik et al. reported organohydrogel hybrids that they claim 
limited diffusion of different monomer or polymer solutions in high viscosities and 
crosslinked them to obtain chemically and physically distinct regions (Figure 5.6). 
They also showed that a single monomer N,N-dimethylacrylamide solution can be 
used with different crosslinkers to obtain organohydrogels with distinct zones.
50
  
 
Figure 5.6. Fabrication of macroscopic organohydrogel by preventing diffusion of 
different monomers and polymers.
50
 
In this chapter we report a method of organohydrogel formation that does not rely on 
adhesion or limiting diffusion of reactants by high viscosities, but rather on the side 
chain deprotection by natural diffusion control. In our method the connection at the 
interface is thus not an issue because our gel backbone was initially crosslinked and 
only the side chains of the polymers are changed. This solves the issue of gel 
interconnectivity. This finding was further exploited to create hydrogel patterns on a 
hydrophobic film. We believe that a similar concept can be applied to different 
polymers with functional side chains, as long as the speed of the reaction taking place 
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at the side chain is equal to or not much different than the diffusion speed of the 
modifying agent through the polymer network. 
5.2. Results and Discussion 
5.2.1 Tryptophan Based Hydrogel 
Tryptophan based hydrogels were prepared by crosslinking lysine and glutamic acid 
containing copolypeptides in their protected forms using hexamethylene-bisTAD 
(HM-bisTAD) (Figure 5.7). Firstly, TAD-tryptophan crosslinking resulted in a 
polypeptide organogel. Then, cationic (lysine) and anionic (glutamic acid) hydrogels 
were obtained by deprotection of the hydrophobic groups of these organogels.  
 
Figure 5.7. Synthesis of hydrogel via TAD-tryptophan crosslinking and deprotection. 
5.2.1.1 Copolypeptide Compositions and Gelation Kinetics  
A library of tryptophan containing copolypeptides was prepared according to the 
procedure described in the previous chapter. Table 5.1 shows the properties and  
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gelation kinetics of the copolypeptides into organogels. The gelation speed was found 
to be proportional to the amount of tryptophan present. The kinetics of gelation can 
also be controlled by different solvent compositions. In general, the gelation speed 
decreases with increasing solvent polarity. Additionally, the concentration of polymer 
solution can also be used to tune kinetics. 
Table 5.1. Summary of the polypeptides used in hydrogel synthesis. 
Polymer Feed Comp. SEC(a) 
Mn, Đ 
Theo. 
Mw 
% Trp(b) bisTAD/
Trp 
Trp 
Gelation 
Time(c) 
L1 Lys70Trp30 11K, 1.1 23070 24.3 1:2 1-2 min 
L1-50 Lys70Trp30 11K, 1.1 23070 24.3 1:4 2-3 mins 
L2 Lys80Trp20 13K, 1.1 23690 15.8 1:2 8 mins 
L2-50 Lys80Trp20 13K, 1.1 23690 15.8 1:4 1 hour 
L3 Lys90Trp10 12K, 1.1 24311 7.7 1:2 1.5 hours 
B1 Blg70Trp30 10K, 1.1 21104 26.6 1:2 1-2 mins 
B2 Blg80Trp20 12K, 1.1 21424 17.4 1:2 6 mins 
B3 Blg90Trp10 8K, 1.1 21785 8.6 1:2 40 mins 
(a) Measured in DMF against PS. (b) Calculated theoretically. (c) solvent mixture 
chloroform:acetonitrile (50:50). 
SEC results showed that copolymerization of tryptophan with Z-lysine (L-series) and 
γ-benzyl-glutamate (B-series) resulted in polypeptides with low PDI and symmetrical 
distributions (Figures 5.8 and 5.9). These polypeptides are soluble in organic solvents, 
including chloroform and DMF. The choice of solvent is very important to obtain 
perfect gels. As mentioned before, the TAD-tryptophan reaction is very slow in DMF, 
which is also a highly hygroscopic solvent. This means that some portion of TAD may 
be decompose by water (in DMF) unless very high quality anhydrous fresh DMF is 
used. The TAD-tryptophan reaction is generally very fast in chloroform. This prevents 
thorough mixing of the reactants before the reaction sets in. We found that a 
chloroform/acetonitrile mixture is ideal for the crosslinking reactions. The gelation 
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speed can be controlled by the composition of solvent mixtures, lower concentrations 
of chloroform resulting in a decreased gelation rate.         
 
Figure 5.8. GPC chromatograms of the B series. Dispersity is between 1.05 and 1.08. 
 
Figure 5.9. GPC chromatograms of the L series. Dispersity is between 1.08 and 1.1. 
5.2.1.2 Hydrogel Synthesis 
Two different approaches were tested to obtain hydrogels from these polypeptides. The 
first approach was to make a polypeptide in its deprotected form and crosslink it 
directly with HM-bisTAD to obtain the hydrogel (Figure 5.10). This approach was 
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quite limited by the insolubility of the deprotected polypeptide. Indeed, only very short 
copolypeptides (up to 15-20 repeating units) were soluble in DMF and the crosslinking 
reaction was quite slow in DMF, approximately 1-3 hours. The second method 
involved the crosslinking of protected polypeptide first and then deprotecting it to 
obtain hydrogels (Figure 5.11). This approach allowed us to prepare hydrogels with 
any length of polypeptide since solubility is not an issue for the protected polypeptides. 
Additionally, the protected forms do not interfere with the crosslinking reaction 
whereas a deprotected lysine may react with TAD. Moreover, TAD instability in water 
also disfavors the first approach. 
 
Figure 5.10. TAD crosslinking of Poly(lys-st-trp). 
In order to convert organogels into hydrogels, the hydrophobic protecting groups have 
to be removed. Different protecting groups require individual deprotection methods to 
convert the organogels into hydrogel. In general, for ionic amino acid residues they 
have to be ionized after deprotection to obtain a swollen hydrogel. Additionally, 
washing steps after deprotection should be selected according to the deprotection 
chemistry. It is important to remove acidic residues or other side products after 
deprotection, which might otherwise cause hydrolysis of the hydrogel. Here, the 
hydrogels were washed with DMF to remove all acids. In case of Z-lysine, 
deprotection with HBr (in acetic acid) followed by washing with deionized water was 
sufficient to obtain hydrogels. However, in the case of glutamic acid, carboxylic acid 
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groups require treatment with a K2CO3 solution for ionization to achieve 
hydrophilicity. We observed that if the hydrogels were not washed properly, they 
break apart due to hydrolysis. On the other hand, properly washed hydrogels were 
stable for at least 8 months (to date) at room temperature in deionized water. 
 
Figure 5.11. TAD crosslinking of poly(Z-lys-st-trp) and subsequent deprotection to 
form hydrogels. 
5.2.1.3 Mechanical Analyses of Hydrogels 
Organogels of all the copolypeptides described in Table 1 formed elastic and strong 
materials. Lesser crosslinked organogel have more transparent appearance (Figure 
5.12). Sometimes orange colored gels were observed due to small amounts of 
unreacted TAD left in the gel. Gels obtained from the lysine L-series are denoted as 
OL# (organogel) and HL# (hydrogel), or accordingly when obtained from the glutamic 
acid B-series. 
Mechanical studies were done on five replicates of each cylindrical shaped gel of 
approximately 2 cm diameter and 1 cm height Figure 5.13 shows the average results of 
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these tests. The less crosslinked hydrogels had lower Young moduli (50% crosslinked 
L1 and L2). Interestingly, there was no significant difference between B1 and B2 
unlike between L1 and L2. The results showed that the ranges of the Young moduli of 
hydrogels are between 2-12 kPa (Figure 5.13). This range is suitable for tissue 
engineering applications. A recent study showed that optimal elastic modulus is 60 kPa 
for bone formation and repair.
57
 In general, a reasonable modulus for a scaffold is 
between 0.01kPa-15kPa for hard tissues and 0.0004-0.35 kPa for soft tissues.
58 
 
 
 
Figure 5.12. Organogels derived from the lysine L-series (OL1, OL2, OL3) and 
hydrogel of OL1 (HL1). Approximately 50 % crosslinked. The ruler in the photo is 
metric. 
 
Figure 5.13. Mechanical analyses of hydrogels. These tests were done with hydrogels 
swollen in PBS buffer. L1 and L2 approximately 50% crosslinked; other samples fully 
crosslinked. 
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Unconfined compression testing with impermeable platens was used to determine the 
effect hydrogel composition on the Young’s modulus. Testing was carried out using a 
Z050 materials testing machine (Zwick/Roell, Germany) equipped with a 5 N S-type 
load cell. Samples were hydrated in PBS for 1 hour prior to testing and the 
compression tests were carried out in a bath of PBS.  Samples were compressed to 
10% strain at a rate of 10%/min. The Young’s modulus was then calculated from a fit 
to the linear region of the stress strain curve. A preload of 5 mN was used to establish 
contact between the sample and the upper platen in addition to serving as a measure of 
sample height. 
5.2.1.4 Cell Studies 
Biocompatibility studies were done on L1 and B1 hydrogels as they contain the 
highest concentration of crosslinker. Human stem cells were used to investigate 
cytotoxicity with gel composition.  Figure 5.14 shows the result of study and 
highlights that there is no sign of cell toxicity. In the first 72 hours, cells survived and 
multiplied as evident from their metabolic activity. At longer exposure time a slight 
drop of metabolic activity was observed for both gels relative to the cells alone. This 
effect was more pronounced for the B1 hydrogel at a metabolic activity around 62% 
after 7 days, while L1 retained a metabolic activity similar to the control group 
suggesting no cytotoxic effect. Fluorescence microscope image of the cell seeded 
hydrogels (Figure 5.15) confirm the good cell viability. 
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Figure 5.14. Cell viability test of the hydrogels L1 and B1 
 
Figure 5.15. Fluorescence microscope images after 72 hours stem cell interactions 
with hydrogels. C is the control group, B is hydrogel B1 and L is hydrogel L1. 
5.2.1.5 SEM Results 
SEM images of the hydrogels were taken after freeze drying (Figure 5.16). B1 and B2 
did not show a noticeable porous microstructure, whereas the L-gels exhibited this 
structure. L1-50 and L2 had a homogenous porous structure, and L1 had a 
heterogeneous pore distribution. The pores of L3 were much bigger and random in 
sizes. The SEM results show that optimization of gelation parameters has the potential 
to facilitate porous microstructures.  
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Figure 5.16. SEM images of the freeze-dried gels. a) B1 b) B2 c) L1-50 d) L1 e) L2  
f) L3. 
5.2.2 A New Class of Organohydrogel 
5.2.2.1 The Phenomenon and Synthesis of Organohydrogel 
The first trials for converting L series organogels into hydrogels resulted in unusual 
looking heterogeneous materials where some parts were hydrogel and some parts 
appeared untouched. After examination of these materials we observed that hydrogel 
formation occurred at the outside covering an organogel inner material. This 
observation confirmed that the deprotection of the hydrogel begins from the outer 
surface and follows the diffusion of the deprotecting agent. We believe that this is due 
to the slow diffusion of acid in a solid hydrophobic gel network (deprotection speed  ≥ 
diffusion speed). It was hypothesized that the slow diffusion was caused by the 
shrinking of the deprotected networks (deprotection medium is a poor solvent for 
hydrogel) (Figure 5.17). Having these findings in hand, we tested this hypothesis by 
preparing smooth cylindrical gels and deprotected them under gentle conditions (non-
stirring). The very first test was done with a short polypeptide with a composition of 
poly(Z-Lys10-st-Trp5) which is soluble in DMF in its protected and deprotected form. 
a b c 
d e f 
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After crosslinking with HM-bisTAD (Figure 18a), the organogel was placed into a 
TFA/CHCl3 solvent mixture and treated with HBr (in acetic acid) (Figure 5.18b). After 
1-2 hours, the material was taken from the solution and washed with diethyl ether. At 
this stage the material had shrunk and became opaque. Finally, it was placed into DMF 
and left until fully swollen (Figure 5.18c). Two distinct regions (as symmetrical core-
shells) were observed (Figure 5.18c) where unreacted hydrophobic HM-bisTAD 
residues accumulated in the hydrophobic core. 
 
Figure 5.17. Schematic illustration of organohydrogel synthesis. 
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Figure 5.18. Partial deprotection of organogel. a) Organogel having unreacted TAD b) 
The gel in (a) was placed into deprotection medium c) Partially deprotected gel 
washed and swollen in DMF 
We further tested organohydrogel formation with longer chain polypeptides such as 
poly(Lys70-st-Trp30), Mw:11K, and observed the same core shell structure after 
optimization of deprotection time and acid amount. The timing of the deprotection 
procedure is critical as for overnight  deprotection and 1:4 (CBz:HBr) equivalent acids, 
the material completely turned into a hydrogel. On the other hand, decreasing the time 
to 1h under the same condition resulted in an organohydrogel. The main difference of 
these longer polypeptide chains was the opacity in DMF, so the core-shell structure 
was not seen as clearly as in Figure 5.18c. However, in water the transparent hydrogel 
shell and opaque core was easily distinguishable (Figure 5.19).   
 c 
 b 
 c  a 
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Figure 5.19. Organohydrogel synthesis by partial deprotection of CBZ groups on 
lysine. 
5.2.2.2 SEM and ESEM Results 
SEM (Figure 5.20) and ESEM (Figure 5.21) images demonstrate that the shell network 
expanded while the core network was collapsed. Interestingly, they belong to the same 
network since the material backbone and crosslinking was not affected during CBZ 
group removal.  
When all organic solvent was removed from the core by washing, the material became 
extremely hard and brittle at the core level and very soft at the shell level. At this stage, 
the organohydrogel’s composition is similar to a peach (very soft hydrophilic shell and 
with a hard seed at the core). This made cutting of the gel challenging because of core 
breakage. Therefore, there is a slight height difference between the regions in both the 
SEM and ESEM images. However, the difference between core and shell is easily 
distinguishable with both analyses. 
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Figure 5.20. SEM images of a hybrid gel after freeze drying. a represents freeze dried 
gel. b, c and d zoomed circles. Border (e) image scale is 30µm.  
 
Figure 5.21. ESEM images of a wet hybrid gel. a) Shell-100 µm b) Core-100 µm c) 
Shell-30 µm d) Core-30 µm and e) Border-100 µm 
 
 
139 
 
5.2.2.3 Dyeing of the Material  
Hydrophobic hexamethylene-bisTAD has a distinguishable red color which was used 
to monitor hydrophobic or non-deprotected areas of the gel. Figure 5.22 shows 
representative examples of synthesized organohydrogels. Initially, we started the 
washing steps with diethylether after treatment with acid. Then we realized that it 
creates internal pressure inside the gel, due to the high vapor pressure of ether and the 
heat produced by mixing the washing solvents. As a result, gels cracked (Figure 5.22 
a) and therefore, this method was abandoned and gels only washed with excess DMF.  
 
Figure 5.22. a) A cracked gel due to internal pressure of trace ether which increased 
with the heat of DMF-H2O mixing. b) The gel broken into two almost identical pieces 
c) The piece (2) was washed with excess DMF to remove unreacted TAD – this photo 
was taken in H2O. d) TAD free gel was placed into Rhodamine B solution overnight 
and washed. e) Piece (1) was washed partial with DMF to show TAD free and TAD 
containing areas and then dyed with Rhodamine B to show hydrophilic areas. 
 
Similiarly, a core-shell organohydrogel was dyed with Rhodamine B when it is one 
piece (Figure 5.23a). Then it was cut into half and observed that core was not dyed 
(Figure 5.23b). Another gel was kept in THF and dyed with Reichardt’s dye. After 
swollen in water the core was seen dyed (Figure 5.23c).  
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Figure 5.23. a) Excess-TAD free gel was dyed with Rhodamine B. b) The gel was cut 
into pieces showing that the core was not dyed with Rhodamine B, c) Another 
organohydrogel was dyed with Reichardt's dye in THF followed by resweeling in 
water, showing hydrophic dye in the core. 
5.2.2.4 Patterning of Organogel Film 
TAD-tryptophan crosslinked gels can be made in any shape such as cylinder, film or 
the shape of a mold. Thin films of polypeptide gel were prepared in glass petri dishes 
(Figure 24). Then, deprotection of different regions was achieved by placing drops of 
deprotecting acid as patterns on the organogel. IR spectrum showed exactly the same 
results for deprotected (patterned) and protected (untouched) parts. This is because the 
patterned layer was thin and sits on a protected film. Then the gels were covered with 
an aqueous solution of  hydrophilic Rhodamine B. After washing only the patterned 
parts were dyed pink indicating the presence of Rhodamine B in these hydrophilic 
regions. We believe that by optimizing conditions and with better equipment or setup, 
this method will provide complex patterns for different type of applications. For 
example, 3D-printers can be utilized through a double-syringe mixer where one 
syringe contains polypeptide and a crosslinker is in the other syringe. Partial 
deprotection of different shapes forms completely unique hybrid materials.  
 
a b c 
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Figure 5.24. Top: mixing a P6 with HM-bisTAD at different times. a) HBr solution 
was dropped by TLC capillary tube to create a pattern b) Patterned film washed with 
DMF and water c) Washed film was dyed with Rhodamine B. 
5.3. Conclusions 
In conclusion, tryptophan-TAD chemistry was used to crosslink tryptophan containing 
statistical copolypeptides. Hydrogels were obtained by removal of hydrophobic 
protection group of lysine and glutamic acid. Cytotoxicity essay, mechanical analyses 
and SEM results showed that these hydrogels has a high potential to be used as 
biomaterials.  
Observation of diffusion controlled deprotection of hydrophobic groups was exploited 
to create new class of core-shell type organohydrogels. Similarly, this concept was 
used to create thin hydrophilic patterns on a hydrophobic film. 
a b c 
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5.4. Experimental 
Synthesis of the organogels: In general, 150 mg of polypeptide was dissolved in 1.5 
mL chloroform-acetonitrile (1:1) mixture. To this solution, HM-TAD from a stock 
solution (33 mg/mL in chloroform-acetonitrile 1:2) was quickly added and the solution 
was shaken vigorously for 20-30 seconds. Then, the solution was kept standing for 
gelation. The gelation time was determined by the vial tilting method.  
Synthesis of the hydrogels: The organogel obtained was placed into an oven dried 
vial and approximately 10 mL of chloroform was added. To this mixture, 1 mL of HBr 
in acetic acid (33%) was added and stirred for 8 hours. Then, solvent was removed by 
decanting. After, the gel was washed with chloroform twice and placed into a vial 
containing 15 mL of anhydrous DMF. The gel was kept for 30 minutes in this solution 
and solution refreshed with DMF again. This step was repeated for 4 times. Then, the 
gel was taken and placed into a beaker containing ice cold-deionized water. The 
shrunken gel, specifically lysine containing gels, started to swell in water. At this step 
the gel was dialyzed against deionized water for 2 days to remove the DMF.  
Glutamic acid containing gels (B1 and B2) were swelled in basic aqueous solution at 
pH 10.5-11. After, 1 or 2 days the completely swelled gel was then dialyzed with 
deionized water to neutralize the solution.  
Importantly, if the gels start breaking apart in the dialysis step, it indicates that there is 
still acid left in the gel. To prevent this, less HBr and given longer times for 
deprotection or increase the number of DMF steps can be used. A well washed gel 
should be in one piece and strong enough to hold and squeeze slightly.   
Synthesis of the core-shell hybrid gel: An L series organogel was obtained in 
accordance with the procedure above. Then, it was placed into an oven dried vial and 
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10 mL of chloroform was added with 0.5 mL HBr (33% in acetic acid). The mixture 
was shaken and let stand for 1 hour. Then, the solvent was removed by decanting. 
Afterwards, the gel was washed with chloroform twice and placed into vial containing 
15 mL of anhydrous DMF. The gel was kept for 30 minutes in this solution and then 
the solution was refreshed with DMF again. This step was repeated for 4 times. Then, 
the gel was taken and placed into beaker containing ice cold-deionized water. The 
shrunken gel was started to swell in water for lysine containing gels. At this step the 
gel was dialyzed against deionized water for 2 days to remove the DMF. Different 
procedures such as 0.1 mL HBr and overnight reaction also resulted in similar core-
shell organohydrogels.  
During washing steps, the immiscible layer of previous solvent (like chloroform) also 
follows a diffusion pattern while leaving the gel. Therefore, in cases of complete 
deprotection, it could be assumed that the completely deprotected hydrogel is a core-
shell organohydrogel. To distinguish between two, the gel should be washed very well. 
A succesfull core-shell organohydrogel should keep its hard, opaque, symmetric core 
after washing, deswelling in different medium or reswelling after freeze drying. If this 
structure is not present, it indicates that gel was already a hydrogel and the pattern 
observed was only solvent differences trapped in the gel. In this case the procedure can 
be optimized by reducing acid amount or reaction time to obtain a proper core-shell 
organohydrogel.  
 Patterning trials on organogel film: 500 mg of an L series polypeptide was 
dissolved in 7.5 mL chloroform-acetonitrile (1:1). Next, 50 mg HM-bisTAD in 1.5 mL 
chloroform-acetonitrile (1:1) was added to the solution and shaken. Then, the solution 
was slowly added into a clean glass petri dish with a Pasteur pipette. After 10-20 min 
the pink color of the TAD disappeared, indicating there is no free TAD left in the film. 
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The film was left for 2-3 hours in open air to remove most of the solvent absorbed by 
the gel. Then, using a commercially available TLC capillary tube a 1/10 diluted 
solution of HBr (33% in acetic acid) in chloroform was put on the gel as droplets. 
After, 15 minutes the droplets and the film were washed with DMF and then with 
deionized water.     
Dying the core-shell hybrid gel: Gels were placed into a beaker containing 
Rhodamine B (20mg/L) and kept overnight. Then, dyed gels were dialyzed against 
deionized water for 2 days and the water was refreshed at least 3 times a day. The 
same procedure was also applied to the patterned film. To test dying of the core, a gel 
was placed in 200 mL THF and immediately started to shrink. Then, Reichardt's dye 
(~5-10 mg) was dissolved and the gel was kept in this solution overnight. Finally, the 
gel was dialyzed with deionized water for 2 days by and the water was refreshed at 
least 3 times a day.  
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 Chapter 6 
 Conclusion and outlook 
The aim of this Ph.D. project was to synthesize cross-linked polypeptide based 
hydrogels derived from N-carboxyanhydride polymerization. The focus was on the 
development of a method that allows the fabrication of mechanically strong gels which 
may find application in tissue engineering or drug delivery. 
In Chapter 2 we have attempted to crosslink tyrosine containing polypeptides by 
Horseradish Peroxidase enzyme. Varieties of polypeptides have been tested for 
crosslinking but none of them formed a hydrogel. Having tyrosine polypeptides in our 
hand we searched for alternative tyrosine selective reactions in literature. This led to 
the investigation of triazolinedione (TAD) compounds as crosslinking agents for 
copolypeptides in Chapter 3. TAD compounds were synthesized and tyrosine-TAD 
reactions was optimized for our polypeptides. In this chapter we have successfully 
functionalized tyrosine containing polypeptides by PTAD, TAD-carboxylic acid and 
crosslinked those polypeptide by HM-bisTAD. The main challenge and limitation for 
tyrosine-TAD reaction was the instability of TAD compounds in aqueous conditions. 
In Chapter 4, switching from tyrosine to tryptophan has opened a new way to 
functionalize copolypeptides. Unlike most of the functional amino acids, tryptophan 
did not require protection-deprotection chemistry for polymerization. Additionally, 
tryptophan-TAD reaction has been carried out in organic solvents in which TADs are 
stable. Demonstration of successful co-click reaction showed that this method has high 
potential to prepare well defined polypeptides with an ease. In the last chapter, the 
TAD-tryptophan reaction was utilized to obtain mechanically strong hydrogels. The 
versatility of the reaction has provided the consistency and the reproducibility for 
fabrication of polypeptide based hydrogels. Control over gelation kinetics was 
150 
 
achieved by varying the amount of tryptophan in the copolypeptide. At the end of this 
chapter a new type of organohydrogel was reported. It was formed by deprotection of 
Cbz groups of lysine via diffusion control.   
While the Trytophan-TAD reaction can be used to conjugate polypeptides, applying 
this reaction for crosslinking has higher future potential for bioapplications. Synthesis 
of functional TADs is challenging which probably limits its applicability in the 
conjugation/functionalization of polymers. Difunctional, hydrophobic TADs can, 
however, readily been synthesized and stored. Their reaction with tryptophan is fast 
and selective, which makes it ideally suited for cross-linking reactions. In continuation 
of this work, the design of biomedically relevant hydrogels by this technique should be 
focused on. For example, 3D-printers can be utilized to create very complex hydrogels 
by using double-syringe mixer where one syringe contains polypeptide and a TAD 
crosslinker in the other syringe. It could be done by choosing proper composition of 
solvents, polymer/TAD. The gelation time can be tuned to 1 second or much lower to 
achieve a fast 3D printing. On the other hand 3D printed molds can be used to fabricate 
complex shape hydrogels.  
In future, new approaches to pattern cross-linked polypeptides should also be 
investigated. 
 
 
 
 
 
